<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVEQ" lang="spa" raw_text_char_length="4479" raw_text_md5="ab8f0d43b1807334f0faa1a060165d3f" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="40" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Todo lo que hay que saber del remdesivir</ORIGINAL_TEXT>
<TOKEN end_char="4" id="token-0-0" morph="none" pos="word" start_char="1">Todo</TOKEN>
<TOKEN end_char="7" id="token-0-1" morph="none" pos="word" start_char="6">lo</TOKEN>
<TOKEN end_char="11" id="token-0-2" morph="none" pos="word" start_char="9">que</TOKEN>
<TOKEN end_char="15" id="token-0-3" morph="none" pos="word" start_char="13">hay</TOKEN>
<TOKEN end_char="19" id="token-0-4" morph="none" pos="word" start_char="17">que</TOKEN>
<TOKEN end_char="25" id="token-0-5" morph="none" pos="word" start_char="21">saber</TOKEN>
<TOKEN end_char="29" id="token-0-6" morph="none" pos="word" start_char="27">del</TOKEN>
<TOKEN end_char="40" id="token-0-7" morph="none" pos="word" start_char="31">remdesivir</TOKEN>
<TRANSLATED_TEXT>Everything you need to know about the remedigger</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="109" id="segment-1" start_char="44">
<ORIGINAL_TEXT>Viales de remdesivir en las instalaciones de Gilead en California.</ORIGINAL_TEXT>
<TOKEN end_char="49" id="token-1-0" morph="none" pos="word" start_char="44">Viales</TOKEN>
<TOKEN end_char="52" id="token-1-1" morph="none" pos="word" start_char="51">de</TOKEN>
<TOKEN end_char="63" id="token-1-2" morph="none" pos="word" start_char="54">remdesivir</TOKEN>
<TOKEN end_char="66" id="token-1-3" morph="none" pos="word" start_char="65">en</TOKEN>
<TOKEN end_char="70" id="token-1-4" morph="none" pos="word" start_char="68">las</TOKEN>
<TOKEN end_char="84" id="token-1-5" morph="none" pos="word" start_char="72">instalaciones</TOKEN>
<TOKEN end_char="87" id="token-1-6" morph="none" pos="word" start_char="86">de</TOKEN>
<TOKEN end_char="94" id="token-1-7" morph="none" pos="word" start_char="89">Gilead</TOKEN>
<TOKEN end_char="97" id="token-1-8" morph="none" pos="word" start_char="96">en</TOKEN>
<TOKEN end_char="108" id="token-1-9" morph="none" pos="word" start_char="99">California</TOKEN>
<TOKEN end_char="109" id="token-1-10" morph="none" pos="punct" start_char="109">.</TOKEN>
<TRANSLATED_TEXT>Refreshment tours at Gilead facilities in California.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="280" id="segment-2" start_char="113">
<ORIGINAL_TEXT>Cualquier avance para frenar el coronavirus es bienvenido, pero, igual que sucede con el mismo virus, aún falta mucho por saber sobre este fármaco que ha aprobado EEUU.</ORIGINAL_TEXT>
<TOKEN end_char="121" id="token-2-0" morph="none" pos="word" start_char="113">Cualquier</TOKEN>
<TOKEN end_char="128" id="token-2-1" morph="none" pos="word" start_char="123">avance</TOKEN>
<TOKEN end_char="133" id="token-2-2" morph="none" pos="word" start_char="130">para</TOKEN>
<TOKEN end_char="140" id="token-2-3" morph="none" pos="word" start_char="135">frenar</TOKEN>
<TOKEN end_char="143" id="token-2-4" morph="none" pos="word" start_char="142">el</TOKEN>
<TOKEN end_char="155" id="token-2-5" morph="none" pos="word" start_char="145">coronavirus</TOKEN>
<TOKEN end_char="158" id="token-2-6" morph="none" pos="word" start_char="157">es</TOKEN>
<TOKEN end_char="169" id="token-2-7" morph="none" pos="word" start_char="160">bienvenido</TOKEN>
<TOKEN end_char="170" id="token-2-8" morph="none" pos="punct" start_char="170">,</TOKEN>
<TOKEN end_char="175" id="token-2-9" morph="none" pos="word" start_char="172">pero</TOKEN>
<TOKEN end_char="176" id="token-2-10" morph="none" pos="punct" start_char="176">,</TOKEN>
<TOKEN end_char="182" id="token-2-11" morph="none" pos="word" start_char="178">igual</TOKEN>
<TOKEN end_char="186" id="token-2-12" morph="none" pos="word" start_char="184">que</TOKEN>
<TOKEN end_char="193" id="token-2-13" morph="none" pos="word" start_char="188">sucede</TOKEN>
<TOKEN end_char="197" id="token-2-14" morph="none" pos="word" start_char="195">con</TOKEN>
<TOKEN end_char="200" id="token-2-15" morph="none" pos="word" start_char="199">el</TOKEN>
<TOKEN end_char="206" id="token-2-16" morph="none" pos="word" start_char="202">mismo</TOKEN>
<TOKEN end_char="212" id="token-2-17" morph="none" pos="word" start_char="208">virus</TOKEN>
<TOKEN end_char="213" id="token-2-18" morph="none" pos="punct" start_char="213">,</TOKEN>
<TOKEN end_char="217" id="token-2-19" morph="none" pos="word" start_char="215">aún</TOKEN>
<TOKEN end_char="223" id="token-2-20" morph="none" pos="word" start_char="219">falta</TOKEN>
<TOKEN end_char="229" id="token-2-21" morph="none" pos="word" start_char="225">mucho</TOKEN>
<TOKEN end_char="233" id="token-2-22" morph="none" pos="word" start_char="231">por</TOKEN>
<TOKEN end_char="239" id="token-2-23" morph="none" pos="word" start_char="235">saber</TOKEN>
<TOKEN end_char="245" id="token-2-24" morph="none" pos="word" start_char="241">sobre</TOKEN>
<TOKEN end_char="250" id="token-2-25" morph="none" pos="word" start_char="247">este</TOKEN>
<TOKEN end_char="258" id="token-2-26" morph="none" pos="word" start_char="252">fármaco</TOKEN>
<TOKEN end_char="262" id="token-2-27" morph="none" pos="word" start_char="260">que</TOKEN>
<TOKEN end_char="265" id="token-2-28" morph="none" pos="word" start_char="264">ha</TOKEN>
<TOKEN end_char="274" id="token-2-29" morph="none" pos="word" start_char="267">aprobado</TOKEN>
<TOKEN end_char="279" id="token-2-30" morph="none" pos="word" start_char="276">EEUU</TOKEN>
<TOKEN end_char="280" id="token-2-31" morph="none" pos="punct" start_char="280">.</TOKEN>
<TRANSLATED_TEXT>Any progress in stopping coronavirus is welcome, but, like the same virus, there is still much to learn about this drug that has been approved by the US.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="323" id="segment-3" start_char="283">
<ORIGINAL_TEXT>Pregunta: ¿Qué es exactamente remdesivir?</ORIGINAL_TEXT>
<TOKEN end_char="290" id="token-3-0" morph="none" pos="word" start_char="283">Pregunta</TOKEN>
<TOKEN end_char="291" id="token-3-1" morph="none" pos="punct" start_char="291">:</TOKEN>
<TOKEN end_char="293" id="token-3-2" morph="none" pos="punct" start_char="293">¿</TOKEN>
<TOKEN end_char="296" id="token-3-3" morph="none" pos="word" start_char="294">Qué</TOKEN>
<TOKEN end_char="299" id="token-3-4" morph="none" pos="word" start_char="298">es</TOKEN>
<TOKEN end_char="311" id="token-3-5" morph="none" pos="word" start_char="301">exactamente</TOKEN>
<TOKEN end_char="322" id="token-3-6" morph="none" pos="word" start_char="313">remdesivir</TOKEN>
<TOKEN end_char="323" id="token-3-7" morph="none" pos="punct" start_char="323">?</TOKEN>
<TRANSLATED_TEXT>Question: What exactly is rebroadcasting?</TRANSLATED_TEXT><DETECTED_LANGUAGE>ca</DETECTED_LANGUAGE></SEG>
<SEG end_char="485" id="segment-4" start_char="326">
<ORIGINAL_TEXT>Respuesta: El fármaco desarrollado por Gilead es, según palabras de la misma farmacéutica, un "análogo nucleotídico con actividad antiviral de amplio espectro".</ORIGINAL_TEXT>
<TOKEN end_char="334" id="token-4-0" morph="none" pos="word" start_char="326">Respuesta</TOKEN>
<TOKEN end_char="335" id="token-4-1" morph="none" pos="punct" start_char="335">:</TOKEN>
<TOKEN end_char="338" id="token-4-2" morph="none" pos="word" start_char="337">El</TOKEN>
<TOKEN end_char="346" id="token-4-3" morph="none" pos="word" start_char="340">fármaco</TOKEN>
<TOKEN end_char="359" id="token-4-4" morph="none" pos="word" start_char="348">desarrollado</TOKEN>
<TOKEN end_char="363" id="token-4-5" morph="none" pos="word" start_char="361">por</TOKEN>
<TOKEN end_char="370" id="token-4-6" morph="none" pos="word" start_char="365">Gilead</TOKEN>
<TOKEN end_char="373" id="token-4-7" morph="none" pos="word" start_char="372">es</TOKEN>
<TOKEN end_char="374" id="token-4-8" morph="none" pos="punct" start_char="374">,</TOKEN>
<TOKEN end_char="380" id="token-4-9" morph="none" pos="word" start_char="376">según</TOKEN>
<TOKEN end_char="389" id="token-4-10" morph="none" pos="word" start_char="382">palabras</TOKEN>
<TOKEN end_char="392" id="token-4-11" morph="none" pos="word" start_char="391">de</TOKEN>
<TOKEN end_char="395" id="token-4-12" morph="none" pos="word" start_char="394">la</TOKEN>
<TOKEN end_char="401" id="token-4-13" morph="none" pos="word" start_char="397">misma</TOKEN>
<TOKEN end_char="414" id="token-4-14" morph="none" pos="word" start_char="403">farmacéutica</TOKEN>
<TOKEN end_char="415" id="token-4-15" morph="none" pos="punct" start_char="415">,</TOKEN>
<TOKEN end_char="418" id="token-4-16" morph="none" pos="word" start_char="417">un</TOKEN>
<TOKEN end_char="420" id="token-4-17" morph="none" pos="punct" start_char="420">"</TOKEN>
<TOKEN end_char="427" id="token-4-18" morph="none" pos="word" start_char="421">análogo</TOKEN>
<TOKEN end_char="440" id="token-4-19" morph="none" pos="word" start_char="429">nucleotídico</TOKEN>
<TOKEN end_char="444" id="token-4-20" morph="none" pos="word" start_char="442">con</TOKEN>
<TOKEN end_char="454" id="token-4-21" morph="none" pos="word" start_char="446">actividad</TOKEN>
<TOKEN end_char="464" id="token-4-22" morph="none" pos="word" start_char="456">antiviral</TOKEN>
<TOKEN end_char="467" id="token-4-23" morph="none" pos="word" start_char="466">de</TOKEN>
<TOKEN end_char="474" id="token-4-24" morph="none" pos="word" start_char="469">amplio</TOKEN>
<TOKEN end_char="483" id="token-4-25" morph="none" pos="word" start_char="476">espectro</TOKEN>
<TOKEN end_char="485" id="token-4-26" morph="none" pos="punct" start_char="484">".</TOKEN>
<TRANSLATED_TEXT>Answer: The drug developed by Gilead is, in the words of the same pharmaceutical company, a "nucleotide analogue with broad spectrum antiviral activity."</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="661" id="segment-5" start_char="487">
<ORIGINAL_TEXT>Fue desarrollado para hacer frente a la epidemia de Ébola en África Occidental en 2014 y posteriormente demostró actividad frente a los coronavirus del SARS-CoV y el MERS-CoV.</ORIGINAL_TEXT>
<TOKEN end_char="489" id="token-5-0" morph="none" pos="word" start_char="487">Fue</TOKEN>
<TOKEN end_char="502" id="token-5-1" morph="none" pos="word" start_char="491">desarrollado</TOKEN>
<TOKEN end_char="507" id="token-5-2" morph="none" pos="word" start_char="504">para</TOKEN>
<TOKEN end_char="513" id="token-5-3" morph="none" pos="word" start_char="509">hacer</TOKEN>
<TOKEN end_char="520" id="token-5-4" morph="none" pos="word" start_char="515">frente</TOKEN>
<TOKEN end_char="522" id="token-5-5" morph="none" pos="word" start_char="522">a</TOKEN>
<TOKEN end_char="525" id="token-5-6" morph="none" pos="word" start_char="524">la</TOKEN>
<TOKEN end_char="534" id="token-5-7" morph="none" pos="word" start_char="527">epidemia</TOKEN>
<TOKEN end_char="537" id="token-5-8" morph="none" pos="word" start_char="536">de</TOKEN>
<TOKEN end_char="543" id="token-5-9" morph="none" pos="word" start_char="539">Ébola</TOKEN>
<TOKEN end_char="546" id="token-5-10" morph="none" pos="word" start_char="545">en</TOKEN>
<TOKEN end_char="553" id="token-5-11" morph="none" pos="word" start_char="548">África</TOKEN>
<TOKEN end_char="564" id="token-5-12" morph="none" pos="word" start_char="555">Occidental</TOKEN>
<TOKEN end_char="567" id="token-5-13" morph="none" pos="word" start_char="566">en</TOKEN>
<TOKEN end_char="572" id="token-5-14" morph="none" pos="word" start_char="569">2014</TOKEN>
<TOKEN end_char="574" id="token-5-15" morph="none" pos="word" start_char="574">y</TOKEN>
<TOKEN end_char="589" id="token-5-16" morph="none" pos="word" start_char="576">posteriormente</TOKEN>
<TOKEN end_char="598" id="token-5-17" morph="none" pos="word" start_char="591">demostró</TOKEN>
<TOKEN end_char="608" id="token-5-18" morph="none" pos="word" start_char="600">actividad</TOKEN>
<TOKEN end_char="615" id="token-5-19" morph="none" pos="word" start_char="610">frente</TOKEN>
<TOKEN end_char="617" id="token-5-20" morph="none" pos="word" start_char="617">a</TOKEN>
<TOKEN end_char="621" id="token-5-21" morph="none" pos="word" start_char="619">los</TOKEN>
<TOKEN end_char="633" id="token-5-22" morph="none" pos="word" start_char="623">coronavirus</TOKEN>
<TOKEN end_char="637" id="token-5-23" morph="none" pos="word" start_char="635">del</TOKEN>
<TOKEN end_char="646" id="token-5-24" morph="none" pos="unknown" start_char="639">SARS-CoV</TOKEN>
<TOKEN end_char="648" id="token-5-25" morph="none" pos="word" start_char="648">y</TOKEN>
<TOKEN end_char="651" id="token-5-26" morph="none" pos="word" start_char="650">el</TOKEN>
<TOKEN end_char="660" id="token-5-27" morph="none" pos="unknown" start_char="653">MERS-CoV</TOKEN>
<TOKEN end_char="661" id="token-5-28" morph="none" pos="punct" start_char="661">.</TOKEN>
<TRANSLATED_TEXT>It was developed to address the Ebola epidemic in West Africa in 2014 and subsequently demonstrated activity against SARS-CoV coronaviruses and MERS-CoV.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="713" id="segment-6" start_char="664">
<ORIGINAL_TEXT>Pregunta: ¿Cómo se administra y por cuánto tiempo?</ORIGINAL_TEXT>
<TOKEN end_char="671" id="token-6-0" morph="none" pos="word" start_char="664">Pregunta</TOKEN>
<TOKEN end_char="672" id="token-6-1" morph="none" pos="punct" start_char="672">:</TOKEN>
<TOKEN end_char="674" id="token-6-2" morph="none" pos="punct" start_char="674">¿</TOKEN>
<TOKEN end_char="678" id="token-6-3" morph="none" pos="word" start_char="675">Cómo</TOKEN>
<TOKEN end_char="681" id="token-6-4" morph="none" pos="word" start_char="680">se</TOKEN>
<TOKEN end_char="692" id="token-6-5" morph="none" pos="word" start_char="683">administra</TOKEN>
<TOKEN end_char="694" id="token-6-6" morph="none" pos="word" start_char="694">y</TOKEN>
<TOKEN end_char="698" id="token-6-7" morph="none" pos="word" start_char="696">por</TOKEN>
<TOKEN end_char="705" id="token-6-8" morph="none" pos="word" start_char="700">cuánto</TOKEN>
<TOKEN end_char="712" id="token-6-9" morph="none" pos="word" start_char="707">tiempo</TOKEN>
<TOKEN end_char="713" id="token-6-10" morph="none" pos="punct" start_char="713">?</TOKEN>
<TRANSLATED_TEXT>Question: How is it administered and for how long?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="802" id="segment-7" start_char="716">
<ORIGINAL_TEXT>Respuesta: Remdesivir se fabrica en inyecciones que se administran por vía intravenosa.</ORIGINAL_TEXT>
<TOKEN end_char="724" id="token-7-0" morph="none" pos="word" start_char="716">Respuesta</TOKEN>
<TOKEN end_char="725" id="token-7-1" morph="none" pos="punct" start_char="725">:</TOKEN>
<TOKEN end_char="736" id="token-7-2" morph="none" pos="word" start_char="727">Remdesivir</TOKEN>
<TOKEN end_char="739" id="token-7-3" morph="none" pos="word" start_char="738">se</TOKEN>
<TOKEN end_char="747" id="token-7-4" morph="none" pos="word" start_char="741">fabrica</TOKEN>
<TOKEN end_char="750" id="token-7-5" morph="none" pos="word" start_char="749">en</TOKEN>
<TOKEN end_char="762" id="token-7-6" morph="none" pos="word" start_char="752">inyecciones</TOKEN>
<TOKEN end_char="766" id="token-7-7" morph="none" pos="word" start_char="764">que</TOKEN>
<TOKEN end_char="769" id="token-7-8" morph="none" pos="word" start_char="768">se</TOKEN>
<TOKEN end_char="781" id="token-7-9" morph="none" pos="word" start_char="771">administran</TOKEN>
<TOKEN end_char="785" id="token-7-10" morph="none" pos="word" start_char="783">por</TOKEN>
<TOKEN end_char="789" id="token-7-11" morph="none" pos="word" start_char="787">vía</TOKEN>
<TOKEN end_char="801" id="token-7-12" morph="none" pos="word" start_char="791">intravenosa</TOKEN>
<TOKEN end_char="802" id="token-7-13" morph="none" pos="punct" start_char="802">.</TOKEN>
<TRANSLATED_TEXT>Answer: Remdesivir is manufactured in injections administered intravenously.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1038" id="segment-8" start_char="804">
<ORIGINAL_TEXT>Gilead recuerda que aún se desconoce cuál debe ser la dosis y la duración óptima del tratamiento, pero la autorización de uso de emergencia de la FDA sugiere duraciones de tratamiento de 5 y 10 días, según la gravedad de la enfermedad.</ORIGINAL_TEXT>
<TOKEN end_char="809" id="token-8-0" morph="none" pos="word" start_char="804">Gilead</TOKEN>
<TOKEN end_char="818" id="token-8-1" morph="none" pos="word" start_char="811">recuerda</TOKEN>
<TOKEN end_char="822" id="token-8-2" morph="none" pos="word" start_char="820">que</TOKEN>
<TOKEN end_char="826" id="token-8-3" morph="none" pos="word" start_char="824">aún</TOKEN>
<TOKEN end_char="829" id="token-8-4" morph="none" pos="word" start_char="828">se</TOKEN>
<TOKEN end_char="839" id="token-8-5" morph="none" pos="word" start_char="831">desconoce</TOKEN>
<TOKEN end_char="844" id="token-8-6" morph="none" pos="word" start_char="841">cuál</TOKEN>
<TOKEN end_char="849" id="token-8-7" morph="none" pos="word" start_char="846">debe</TOKEN>
<TOKEN end_char="853" id="token-8-8" morph="none" pos="word" start_char="851">ser</TOKEN>
<TOKEN end_char="856" id="token-8-9" morph="none" pos="word" start_char="855">la</TOKEN>
<TOKEN end_char="862" id="token-8-10" morph="none" pos="word" start_char="858">dosis</TOKEN>
<TOKEN end_char="864" id="token-8-11" morph="none" pos="word" start_char="864">y</TOKEN>
<TOKEN end_char="867" id="token-8-12" morph="none" pos="word" start_char="866">la</TOKEN>
<TOKEN end_char="876" id="token-8-13" morph="none" pos="word" start_char="869">duración</TOKEN>
<TOKEN end_char="883" id="token-8-14" morph="none" pos="word" start_char="878">óptima</TOKEN>
<TOKEN end_char="887" id="token-8-15" morph="none" pos="word" start_char="885">del</TOKEN>
<TOKEN end_char="899" id="token-8-16" morph="none" pos="word" start_char="889">tratamiento</TOKEN>
<TOKEN end_char="900" id="token-8-17" morph="none" pos="punct" start_char="900">,</TOKEN>
<TOKEN end_char="905" id="token-8-18" morph="none" pos="word" start_char="902">pero</TOKEN>
<TOKEN end_char="908" id="token-8-19" morph="none" pos="word" start_char="907">la</TOKEN>
<TOKEN end_char="921" id="token-8-20" morph="none" pos="word" start_char="910">autorización</TOKEN>
<TOKEN end_char="924" id="token-8-21" morph="none" pos="word" start_char="923">de</TOKEN>
<TOKEN end_char="928" id="token-8-22" morph="none" pos="word" start_char="926">uso</TOKEN>
<TOKEN end_char="931" id="token-8-23" morph="none" pos="word" start_char="930">de</TOKEN>
<TOKEN end_char="942" id="token-8-24" morph="none" pos="word" start_char="933">emergencia</TOKEN>
<TOKEN end_char="945" id="token-8-25" morph="none" pos="word" start_char="944">de</TOKEN>
<TOKEN end_char="948" id="token-8-26" morph="none" pos="word" start_char="947">la</TOKEN>
<TOKEN end_char="952" id="token-8-27" morph="none" pos="word" start_char="950">FDA</TOKEN>
<TOKEN end_char="960" id="token-8-28" morph="none" pos="word" start_char="954">sugiere</TOKEN>
<TOKEN end_char="971" id="token-8-29" morph="none" pos="word" start_char="962">duraciones</TOKEN>
<TOKEN end_char="974" id="token-8-30" morph="none" pos="word" start_char="973">de</TOKEN>
<TOKEN end_char="986" id="token-8-31" morph="none" pos="word" start_char="976">tratamiento</TOKEN>
<TOKEN end_char="989" id="token-8-32" morph="none" pos="word" start_char="988">de</TOKEN>
<TOKEN end_char="991" id="token-8-33" morph="none" pos="word" start_char="991">5</TOKEN>
<TOKEN end_char="993" id="token-8-34" morph="none" pos="word" start_char="993">y</TOKEN>
<TOKEN end_char="996" id="token-8-35" morph="none" pos="word" start_char="995">10</TOKEN>
<TOKEN end_char="1001" id="token-8-36" morph="none" pos="word" start_char="998">días</TOKEN>
<TOKEN end_char="1002" id="token-8-37" morph="none" pos="punct" start_char="1002">,</TOKEN>
<TOKEN end_char="1008" id="token-8-38" morph="none" pos="word" start_char="1004">según</TOKEN>
<TOKEN end_char="1011" id="token-8-39" morph="none" pos="word" start_char="1010">la</TOKEN>
<TOKEN end_char="1020" id="token-8-40" morph="none" pos="word" start_char="1013">gravedad</TOKEN>
<TOKEN end_char="1023" id="token-8-41" morph="none" pos="word" start_char="1022">de</TOKEN>
<TOKEN end_char="1026" id="token-8-42" morph="none" pos="word" start_char="1025">la</TOKEN>
<TOKEN end_char="1037" id="token-8-43" morph="none" pos="word" start_char="1028">enfermedad</TOKEN>
<TOKEN end_char="1038" id="token-8-44" morph="none" pos="punct" start_char="1038">.</TOKEN>
<TRANSLATED_TEXT>Gilead recalls that it is still unknown what dose and optimal duration of treatment should be, but the FDA emergency use authorisation suggests 5 and 10 days of treatment, depending on the severity of the disease.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1080" id="segment-9" start_char="1041">
<ORIGINAL_TEXT>Pregunta: ¿Cómo actúa en nuestro cuerpo?</ORIGINAL_TEXT>
<TOKEN end_char="1048" id="token-9-0" morph="none" pos="word" start_char="1041">Pregunta</TOKEN>
<TOKEN end_char="1049" id="token-9-1" morph="none" pos="punct" start_char="1049">:</TOKEN>
<TOKEN end_char="1051" id="token-9-2" morph="none" pos="punct" start_char="1051">¿</TOKEN>
<TOKEN end_char="1055" id="token-9-3" morph="none" pos="word" start_char="1052">Cómo</TOKEN>
<TOKEN end_char="1061" id="token-9-4" morph="none" pos="word" start_char="1057">actúa</TOKEN>
<TOKEN end_char="1064" id="token-9-5" morph="none" pos="word" start_char="1063">en</TOKEN>
<TOKEN end_char="1072" id="token-9-6" morph="none" pos="word" start_char="1066">nuestro</TOKEN>
<TOKEN end_char="1079" id="token-9-7" morph="none" pos="word" start_char="1074">cuerpo</TOKEN>
<TOKEN end_char="1080" id="token-9-8" morph="none" pos="punct" start_char="1080">?</TOKEN>
<TRANSLATED_TEXT>Question: How does it work in our body?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1166" id="segment-10" start_char="1083">
<ORIGINAL_TEXT>Respuesta: Actúa inactivando una enzima que algunos virus necesitan para replicarse.</ORIGINAL_TEXT>
<TOKEN end_char="1091" id="token-10-0" morph="none" pos="word" start_char="1083">Respuesta</TOKEN>
<TOKEN end_char="1092" id="token-10-1" morph="none" pos="punct" start_char="1092">:</TOKEN>
<TOKEN end_char="1098" id="token-10-2" morph="none" pos="word" start_char="1094">Actúa</TOKEN>
<TOKEN end_char="1110" id="token-10-3" morph="none" pos="word" start_char="1100">inactivando</TOKEN>
<TOKEN end_char="1114" id="token-10-4" morph="none" pos="word" start_char="1112">una</TOKEN>
<TOKEN end_char="1121" id="token-10-5" morph="none" pos="word" start_char="1116">enzima</TOKEN>
<TOKEN end_char="1125" id="token-10-6" morph="none" pos="word" start_char="1123">que</TOKEN>
<TOKEN end_char="1133" id="token-10-7" morph="none" pos="word" start_char="1127">algunos</TOKEN>
<TOKEN end_char="1139" id="token-10-8" morph="none" pos="word" start_char="1135">virus</TOKEN>
<TOKEN end_char="1149" id="token-10-9" morph="none" pos="word" start_char="1141">necesitan</TOKEN>
<TOKEN end_char="1154" id="token-10-10" morph="none" pos="word" start_char="1151">para</TOKEN>
<TOKEN end_char="1165" id="token-10-11" morph="none" pos="word" start_char="1156">replicarse</TOKEN>
<TOKEN end_char="1166" id="token-10-12" morph="none" pos="punct" start_char="1166">.</TOKEN>
<TRANSLATED_TEXT>Response: It acts by inactivating an enzyme that some viruses need to replicate.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1320" id="segment-11" start_char="1168">
<ORIGINAL_TEXT>Sin esa enzima (una polimerasa de ARN) los virus, en este caso el SARS-Cov-2, pierden la capacidad de hacer copias de su genoma y seguirse multiplicando.</ORIGINAL_TEXT>
<TOKEN end_char="1170" id="token-11-0" morph="none" pos="word" start_char="1168">Sin</TOKEN>
<TOKEN end_char="1174" id="token-11-1" morph="none" pos="word" start_char="1172">esa</TOKEN>
<TOKEN end_char="1181" id="token-11-2" morph="none" pos="word" start_char="1176">enzima</TOKEN>
<TOKEN end_char="1183" id="token-11-3" morph="none" pos="punct" start_char="1183">(</TOKEN>
<TOKEN end_char="1186" id="token-11-4" morph="none" pos="word" start_char="1184">una</TOKEN>
<TOKEN end_char="1197" id="token-11-5" morph="none" pos="word" start_char="1188">polimerasa</TOKEN>
<TOKEN end_char="1200" id="token-11-6" morph="none" pos="word" start_char="1199">de</TOKEN>
<TOKEN end_char="1204" id="token-11-7" morph="none" pos="word" start_char="1202">ARN</TOKEN>
<TOKEN end_char="1205" id="token-11-8" morph="none" pos="punct" start_char="1205">)</TOKEN>
<TOKEN end_char="1209" id="token-11-9" morph="none" pos="word" start_char="1207">los</TOKEN>
<TOKEN end_char="1215" id="token-11-10" morph="none" pos="word" start_char="1211">virus</TOKEN>
<TOKEN end_char="1216" id="token-11-11" morph="none" pos="punct" start_char="1216">,</TOKEN>
<TOKEN end_char="1219" id="token-11-12" morph="none" pos="word" start_char="1218">en</TOKEN>
<TOKEN end_char="1224" id="token-11-13" morph="none" pos="word" start_char="1221">este</TOKEN>
<TOKEN end_char="1229" id="token-11-14" morph="none" pos="word" start_char="1226">caso</TOKEN>
<TOKEN end_char="1232" id="token-11-15" morph="none" pos="word" start_char="1231">el</TOKEN>
<TOKEN end_char="1243" id="token-11-16" morph="none" pos="unknown" start_char="1234">SARS-Cov-2</TOKEN>
<TOKEN end_char="1244" id="token-11-17" morph="none" pos="punct" start_char="1244">,</TOKEN>
<TOKEN end_char="1252" id="token-11-18" morph="none" pos="word" start_char="1246">pierden</TOKEN>
<TOKEN end_char="1255" id="token-11-19" morph="none" pos="word" start_char="1254">la</TOKEN>
<TOKEN end_char="1265" id="token-11-20" morph="none" pos="word" start_char="1257">capacidad</TOKEN>
<TOKEN end_char="1268" id="token-11-21" morph="none" pos="word" start_char="1267">de</TOKEN>
<TOKEN end_char="1274" id="token-11-22" morph="none" pos="word" start_char="1270">hacer</TOKEN>
<TOKEN end_char="1281" id="token-11-23" morph="none" pos="word" start_char="1276">copias</TOKEN>
<TOKEN end_char="1284" id="token-11-24" morph="none" pos="word" start_char="1283">de</TOKEN>
<TOKEN end_char="1287" id="token-11-25" morph="none" pos="word" start_char="1286">su</TOKEN>
<TOKEN end_char="1294" id="token-11-26" morph="none" pos="word" start_char="1289">genoma</TOKEN>
<TOKEN end_char="1296" id="token-11-27" morph="none" pos="word" start_char="1296">y</TOKEN>
<TOKEN end_char="1305" id="token-11-28" morph="none" pos="word" start_char="1298">seguirse</TOKEN>
<TOKEN end_char="1319" id="token-11-29" morph="none" pos="word" start_char="1307">multiplicando</TOKEN>
<TOKEN end_char="1320" id="token-11-30" morph="none" pos="punct" start_char="1320">.</TOKEN>
<TRANSLATED_TEXT>Without this enzyme (an RNA polymerase), viruses, in this case SARS-Cov-2, lose the ability to make copies of their genome and continue to multiply.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1366" id="segment-12" start_char="1323">
<ORIGINAL_TEXT>Pregunta: ¿Para qué se usará y en qué casos?</ORIGINAL_TEXT>
<TOKEN end_char="1330" id="token-12-0" morph="none" pos="word" start_char="1323">Pregunta</TOKEN>
<TOKEN end_char="1331" id="token-12-1" morph="none" pos="punct" start_char="1331">:</TOKEN>
<TOKEN end_char="1333" id="token-12-2" morph="none" pos="punct" start_char="1333">¿</TOKEN>
<TOKEN end_char="1337" id="token-12-3" morph="none" pos="word" start_char="1334">Para</TOKEN>
<TOKEN end_char="1341" id="token-12-4" morph="none" pos="word" start_char="1339">qué</TOKEN>
<TOKEN end_char="1344" id="token-12-5" morph="none" pos="word" start_char="1343">se</TOKEN>
<TOKEN end_char="1350" id="token-12-6" morph="none" pos="word" start_char="1346">usará</TOKEN>
<TOKEN end_char="1352" id="token-12-7" morph="none" pos="word" start_char="1352">y</TOKEN>
<TOKEN end_char="1355" id="token-12-8" morph="none" pos="word" start_char="1354">en</TOKEN>
<TOKEN end_char="1359" id="token-12-9" morph="none" pos="word" start_char="1357">qué</TOKEN>
<TOKEN end_char="1365" id="token-12-10" morph="none" pos="word" start_char="1361">casos</TOKEN>
<TOKEN end_char="1366" id="token-12-11" morph="none" pos="punct" start_char="1366">?</TOKEN>
<TRANSLATED_TEXT>Question: What will it be used for and in what cases?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1507" id="segment-13" start_char="1369">
<ORIGINAL_TEXT>Respuesta: Esta autorización de emergencia es sólo para el tratamiento de la Covid-19, no está permitido para ningún otro virus o patógeno.</ORIGINAL_TEXT>
<TOKEN end_char="1377" id="token-13-0" morph="none" pos="word" start_char="1369">Respuesta</TOKEN>
<TOKEN end_char="1378" id="token-13-1" morph="none" pos="punct" start_char="1378">:</TOKEN>
<TOKEN end_char="1383" id="token-13-2" morph="none" pos="word" start_char="1380">Esta</TOKEN>
<TOKEN end_char="1396" id="token-13-3" morph="none" pos="word" start_char="1385">autorización</TOKEN>
<TOKEN end_char="1399" id="token-13-4" morph="none" pos="word" start_char="1398">de</TOKEN>
<TOKEN end_char="1410" id="token-13-5" morph="none" pos="word" start_char="1401">emergencia</TOKEN>
<TOKEN end_char="1413" id="token-13-6" morph="none" pos="word" start_char="1412">es</TOKEN>
<TOKEN end_char="1418" id="token-13-7" morph="none" pos="word" start_char="1415">sólo</TOKEN>
<TOKEN end_char="1423" id="token-13-8" morph="none" pos="word" start_char="1420">para</TOKEN>
<TOKEN end_char="1426" id="token-13-9" morph="none" pos="word" start_char="1425">el</TOKEN>
<TOKEN end_char="1438" id="token-13-10" morph="none" pos="word" start_char="1428">tratamiento</TOKEN>
<TOKEN end_char="1441" id="token-13-11" morph="none" pos="word" start_char="1440">de</TOKEN>
<TOKEN end_char="1444" id="token-13-12" morph="none" pos="word" start_char="1443">la</TOKEN>
<TOKEN end_char="1453" id="token-13-13" morph="none" pos="unknown" start_char="1446">Covid-19</TOKEN>
<TOKEN end_char="1454" id="token-13-14" morph="none" pos="punct" start_char="1454">,</TOKEN>
<TOKEN end_char="1457" id="token-13-15" morph="none" pos="word" start_char="1456">no</TOKEN>
<TOKEN end_char="1462" id="token-13-16" morph="none" pos="word" start_char="1459">está</TOKEN>
<TOKEN end_char="1472" id="token-13-17" morph="none" pos="word" start_char="1464">permitido</TOKEN>
<TOKEN end_char="1477" id="token-13-18" morph="none" pos="word" start_char="1474">para</TOKEN>
<TOKEN end_char="1484" id="token-13-19" morph="none" pos="word" start_char="1479">ningún</TOKEN>
<TOKEN end_char="1489" id="token-13-20" morph="none" pos="word" start_char="1486">otro</TOKEN>
<TOKEN end_char="1495" id="token-13-21" morph="none" pos="word" start_char="1491">virus</TOKEN>
<TOKEN end_char="1497" id="token-13-22" morph="none" pos="word" start_char="1497">o</TOKEN>
<TOKEN end_char="1506" id="token-13-23" morph="none" pos="word" start_char="1499">patógeno</TOKEN>
<TOKEN end_char="1507" id="token-13-24" morph="none" pos="punct" start_char="1507">.</TOKEN>
<TRANSLATED_TEXT>Answer: This emergency authorization is only for the treatment of Covid-19, not for any other virus or pathogen.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1764" id="segment-14" start_char="1509">
<ORIGINAL_TEXT>En el caso del coronavirus, la aprobación permite usarlo en pacientes en estado grave: aquéllos que tienen unos bajos niveles de oxígeno en sangre (una saturación de oxígeno por debajo del 94%) o que necesitan soporte respiratorio con ventilación mecánica.</ORIGINAL_TEXT>
<TOKEN end_char="1510" id="token-14-0" morph="none" pos="word" start_char="1509">En</TOKEN>
<TOKEN end_char="1513" id="token-14-1" morph="none" pos="word" start_char="1512">el</TOKEN>
<TOKEN end_char="1518" id="token-14-2" morph="none" pos="word" start_char="1515">caso</TOKEN>
<TOKEN end_char="1522" id="token-14-3" morph="none" pos="word" start_char="1520">del</TOKEN>
<TOKEN end_char="1534" id="token-14-4" morph="none" pos="word" start_char="1524">coronavirus</TOKEN>
<TOKEN end_char="1535" id="token-14-5" morph="none" pos="punct" start_char="1535">,</TOKEN>
<TOKEN end_char="1538" id="token-14-6" morph="none" pos="word" start_char="1537">la</TOKEN>
<TOKEN end_char="1549" id="token-14-7" morph="none" pos="word" start_char="1540">aprobación</TOKEN>
<TOKEN end_char="1557" id="token-14-8" morph="none" pos="word" start_char="1551">permite</TOKEN>
<TOKEN end_char="1564" id="token-14-9" morph="none" pos="word" start_char="1559">usarlo</TOKEN>
<TOKEN end_char="1567" id="token-14-10" morph="none" pos="word" start_char="1566">en</TOKEN>
<TOKEN end_char="1577" id="token-14-11" morph="none" pos="word" start_char="1569">pacientes</TOKEN>
<TOKEN end_char="1580" id="token-14-12" morph="none" pos="word" start_char="1579">en</TOKEN>
<TOKEN end_char="1587" id="token-14-13" morph="none" pos="word" start_char="1582">estado</TOKEN>
<TOKEN end_char="1593" id="token-14-14" morph="none" pos="word" start_char="1589">grave</TOKEN>
<TOKEN end_char="1594" id="token-14-15" morph="none" pos="punct" start_char="1594">:</TOKEN>
<TOKEN end_char="1603" id="token-14-16" morph="none" pos="word" start_char="1596">aquéllos</TOKEN>
<TOKEN end_char="1607" id="token-14-17" morph="none" pos="word" start_char="1605">que</TOKEN>
<TOKEN end_char="1614" id="token-14-18" morph="none" pos="word" start_char="1609">tienen</TOKEN>
<TOKEN end_char="1619" id="token-14-19" morph="none" pos="word" start_char="1616">unos</TOKEN>
<TOKEN end_char="1625" id="token-14-20" morph="none" pos="word" start_char="1621">bajos</TOKEN>
<TOKEN end_char="1633" id="token-14-21" morph="none" pos="word" start_char="1627">niveles</TOKEN>
<TOKEN end_char="1636" id="token-14-22" morph="none" pos="word" start_char="1635">de</TOKEN>
<TOKEN end_char="1644" id="token-14-23" morph="none" pos="word" start_char="1638">oxígeno</TOKEN>
<TOKEN end_char="1647" id="token-14-24" morph="none" pos="word" start_char="1646">en</TOKEN>
<TOKEN end_char="1654" id="token-14-25" morph="none" pos="word" start_char="1649">sangre</TOKEN>
<TOKEN end_char="1656" id="token-14-26" morph="none" pos="punct" start_char="1656">(</TOKEN>
<TOKEN end_char="1659" id="token-14-27" morph="none" pos="word" start_char="1657">una</TOKEN>
<TOKEN end_char="1670" id="token-14-28" morph="none" pos="word" start_char="1661">saturación</TOKEN>
<TOKEN end_char="1673" id="token-14-29" morph="none" pos="word" start_char="1672">de</TOKEN>
<TOKEN end_char="1681" id="token-14-30" morph="none" pos="word" start_char="1675">oxígeno</TOKEN>
<TOKEN end_char="1685" id="token-14-31" morph="none" pos="word" start_char="1683">por</TOKEN>
<TOKEN end_char="1692" id="token-14-32" morph="none" pos="word" start_char="1687">debajo</TOKEN>
<TOKEN end_char="1696" id="token-14-33" morph="none" pos="word" start_char="1694">del</TOKEN>
<TOKEN end_char="1699" id="token-14-34" morph="none" pos="word" start_char="1698">94</TOKEN>
<TOKEN end_char="1701" id="token-14-35" morph="none" pos="punct" start_char="1700">%)</TOKEN>
<TOKEN end_char="1703" id="token-14-36" morph="none" pos="word" start_char="1703">o</TOKEN>
<TOKEN end_char="1707" id="token-14-37" morph="none" pos="word" start_char="1705">que</TOKEN>
<TOKEN end_char="1717" id="token-14-38" morph="none" pos="word" start_char="1709">necesitan</TOKEN>
<TOKEN end_char="1725" id="token-14-39" morph="none" pos="word" start_char="1719">soporte</TOKEN>
<TOKEN end_char="1738" id="token-14-40" morph="none" pos="word" start_char="1727">respiratorio</TOKEN>
<TOKEN end_char="1742" id="token-14-41" morph="none" pos="word" start_char="1740">con</TOKEN>
<TOKEN end_char="1754" id="token-14-42" morph="none" pos="word" start_char="1744">ventilación</TOKEN>
<TOKEN end_char="1763" id="token-14-43" morph="none" pos="word" start_char="1756">mecánica</TOKEN>
<TOKEN end_char="1764" id="token-14-44" morph="none" pos="punct" start_char="1764">.</TOKEN>
<TRANSLATED_TEXT>In the case of coronavirus, approval allows it to be used in patients in severe condition: those who have low blood oxygen levels (oxygen saturation below 94%) or who need mechanical ventilated breathing support.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1889" id="segment-15" start_char="1766">
<ORIGINAL_TEXT>Se dará prioridad a las zonas más afectadas, por lo que pronto podría llegar a Nueva York, epicentro de la pandemia en EEUU.</ORIGINAL_TEXT>
<TOKEN end_char="1767" id="token-15-0" morph="none" pos="word" start_char="1766">Se</TOKEN>
<TOKEN end_char="1772" id="token-15-1" morph="none" pos="word" start_char="1769">dará</TOKEN>
<TOKEN end_char="1782" id="token-15-2" morph="none" pos="word" start_char="1774">prioridad</TOKEN>
<TOKEN end_char="1784" id="token-15-3" morph="none" pos="word" start_char="1784">a</TOKEN>
<TOKEN end_char="1788" id="token-15-4" morph="none" pos="word" start_char="1786">las</TOKEN>
<TOKEN end_char="1794" id="token-15-5" morph="none" pos="word" start_char="1790">zonas</TOKEN>
<TOKEN end_char="1798" id="token-15-6" morph="none" pos="word" start_char="1796">más</TOKEN>
<TOKEN end_char="1808" id="token-15-7" morph="none" pos="word" start_char="1800">afectadas</TOKEN>
<TOKEN end_char="1809" id="token-15-8" morph="none" pos="punct" start_char="1809">,</TOKEN>
<TOKEN end_char="1813" id="token-15-9" morph="none" pos="word" start_char="1811">por</TOKEN>
<TOKEN end_char="1816" id="token-15-10" morph="none" pos="word" start_char="1815">lo</TOKEN>
<TOKEN end_char="1820" id="token-15-11" morph="none" pos="word" start_char="1818">que</TOKEN>
<TOKEN end_char="1827" id="token-15-12" morph="none" pos="word" start_char="1822">pronto</TOKEN>
<TOKEN end_char="1834" id="token-15-13" morph="none" pos="word" start_char="1829">podría</TOKEN>
<TOKEN end_char="1841" id="token-15-14" morph="none" pos="word" start_char="1836">llegar</TOKEN>
<TOKEN end_char="1843" id="token-15-15" morph="none" pos="word" start_char="1843">a</TOKEN>
<TOKEN end_char="1849" id="token-15-16" morph="none" pos="word" start_char="1845">Nueva</TOKEN>
<TOKEN end_char="1854" id="token-15-17" morph="none" pos="word" start_char="1851">York</TOKEN>
<TOKEN end_char="1855" id="token-15-18" morph="none" pos="punct" start_char="1855">,</TOKEN>
<TOKEN end_char="1865" id="token-15-19" morph="none" pos="word" start_char="1857">epicentro</TOKEN>
<TOKEN end_char="1868" id="token-15-20" morph="none" pos="word" start_char="1867">de</TOKEN>
<TOKEN end_char="1871" id="token-15-21" morph="none" pos="word" start_char="1870">la</TOKEN>
<TOKEN end_char="1880" id="token-15-22" morph="none" pos="word" start_char="1873">pandemia</TOKEN>
<TOKEN end_char="1883" id="token-15-23" morph="none" pos="word" start_char="1882">en</TOKEN>
<TOKEN end_char="1888" id="token-15-24" morph="none" pos="word" start_char="1885">EEUU</TOKEN>
<TOKEN end_char="1889" id="token-15-25" morph="none" pos="punct" start_char="1889">.</TOKEN>
<TRANSLATED_TEXT>Priority will be given to the most affected areas, which could soon reach New York, the epicentre of the pandemic in the US.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1937" id="segment-16" start_char="1892">
<ORIGINAL_TEXT>Pregunta: ¿Cuáles son los efectos secundarios?</ORIGINAL_TEXT>
<TOKEN end_char="1899" id="token-16-0" morph="none" pos="word" start_char="1892">Pregunta</TOKEN>
<TOKEN end_char="1900" id="token-16-1" morph="none" pos="punct" start_char="1900">:</TOKEN>
<TOKEN end_char="1902" id="token-16-2" morph="none" pos="punct" start_char="1902">¿</TOKEN>
<TOKEN end_char="1908" id="token-16-3" morph="none" pos="word" start_char="1903">Cuáles</TOKEN>
<TOKEN end_char="1912" id="token-16-4" morph="none" pos="word" start_char="1910">son</TOKEN>
<TOKEN end_char="1916" id="token-16-5" morph="none" pos="word" start_char="1914">los</TOKEN>
<TOKEN end_char="1924" id="token-16-6" morph="none" pos="word" start_char="1918">efectos</TOKEN>
<TOKEN end_char="1936" id="token-16-7" morph="none" pos="word" start_char="1926">secundarios</TOKEN>
<TOKEN end_char="1937" id="token-16-8" morph="none" pos="punct" start_char="1937">?</TOKEN>
<TRANSLATED_TEXT>Question: What are the side effects?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2281" id="segment-17" start_char="1940">
<ORIGINAL_TEXT>Respuesta: La FDA ha notificado los posibles efectos secundarios de este fármaco, entre ellos, aumento de los niveles de enzimas hepáticas -puede ser un signo de inflamación o daño a las células del hígado- y reacciones relacionadas con la perfusión: desde presión arterial baja, pasando por náuseas y vómitos, hasta sudoración y escalofríos.</ORIGINAL_TEXT>
<TOKEN end_char="1948" id="token-17-0" morph="none" pos="word" start_char="1940">Respuesta</TOKEN>
<TOKEN end_char="1949" id="token-17-1" morph="none" pos="punct" start_char="1949">:</TOKEN>
<TOKEN end_char="1952" id="token-17-2" morph="none" pos="word" start_char="1951">La</TOKEN>
<TOKEN end_char="1956" id="token-17-3" morph="none" pos="word" start_char="1954">FDA</TOKEN>
<TOKEN end_char="1959" id="token-17-4" morph="none" pos="word" start_char="1958">ha</TOKEN>
<TOKEN end_char="1970" id="token-17-5" morph="none" pos="word" start_char="1961">notificado</TOKEN>
<TOKEN end_char="1974" id="token-17-6" morph="none" pos="word" start_char="1972">los</TOKEN>
<TOKEN end_char="1983" id="token-17-7" morph="none" pos="word" start_char="1976">posibles</TOKEN>
<TOKEN end_char="1991" id="token-17-8" morph="none" pos="word" start_char="1985">efectos</TOKEN>
<TOKEN end_char="2003" id="token-17-9" morph="none" pos="word" start_char="1993">secundarios</TOKEN>
<TOKEN end_char="2006" id="token-17-10" morph="none" pos="word" start_char="2005">de</TOKEN>
<TOKEN end_char="2011" id="token-17-11" morph="none" pos="word" start_char="2008">este</TOKEN>
<TOKEN end_char="2019" id="token-17-12" morph="none" pos="word" start_char="2013">fármaco</TOKEN>
<TOKEN end_char="2020" id="token-17-13" morph="none" pos="punct" start_char="2020">,</TOKEN>
<TOKEN end_char="2026" id="token-17-14" morph="none" pos="word" start_char="2022">entre</TOKEN>
<TOKEN end_char="2032" id="token-17-15" morph="none" pos="word" start_char="2028">ellos</TOKEN>
<TOKEN end_char="2033" id="token-17-16" morph="none" pos="punct" start_char="2033">,</TOKEN>
<TOKEN end_char="2041" id="token-17-17" morph="none" pos="word" start_char="2035">aumento</TOKEN>
<TOKEN end_char="2044" id="token-17-18" morph="none" pos="word" start_char="2043">de</TOKEN>
<TOKEN end_char="2048" id="token-17-19" morph="none" pos="word" start_char="2046">los</TOKEN>
<TOKEN end_char="2056" id="token-17-20" morph="none" pos="word" start_char="2050">niveles</TOKEN>
<TOKEN end_char="2059" id="token-17-21" morph="none" pos="word" start_char="2058">de</TOKEN>
<TOKEN end_char="2067" id="token-17-22" morph="none" pos="word" start_char="2061">enzimas</TOKEN>
<TOKEN end_char="2077" id="token-17-23" morph="none" pos="word" start_char="2069">hepáticas</TOKEN>
<TOKEN end_char="2079" id="token-17-24" morph="none" pos="punct" start_char="2079">-</TOKEN>
<TOKEN end_char="2084" id="token-17-25" morph="none" pos="word" start_char="2080">puede</TOKEN>
<TOKEN end_char="2088" id="token-17-26" morph="none" pos="word" start_char="2086">ser</TOKEN>
<TOKEN end_char="2091" id="token-17-27" morph="none" pos="word" start_char="2090">un</TOKEN>
<TOKEN end_char="2097" id="token-17-28" morph="none" pos="word" start_char="2093">signo</TOKEN>
<TOKEN end_char="2100" id="token-17-29" morph="none" pos="word" start_char="2099">de</TOKEN>
<TOKEN end_char="2112" id="token-17-30" morph="none" pos="word" start_char="2102">inflamación</TOKEN>
<TOKEN end_char="2114" id="token-17-31" morph="none" pos="word" start_char="2114">o</TOKEN>
<TOKEN end_char="2119" id="token-17-32" morph="none" pos="word" start_char="2116">daño</TOKEN>
<TOKEN end_char="2121" id="token-17-33" morph="none" pos="word" start_char="2121">a</TOKEN>
<TOKEN end_char="2125" id="token-17-34" morph="none" pos="word" start_char="2123">las</TOKEN>
<TOKEN end_char="2133" id="token-17-35" morph="none" pos="word" start_char="2127">células</TOKEN>
<TOKEN end_char="2137" id="token-17-36" morph="none" pos="word" start_char="2135">del</TOKEN>
<TOKEN end_char="2144" id="token-17-37" morph="none" pos="word" start_char="2139">hígado</TOKEN>
<TOKEN end_char="2145" id="token-17-38" morph="none" pos="punct" start_char="2145">-</TOKEN>
<TOKEN end_char="2147" id="token-17-39" morph="none" pos="word" start_char="2147">y</TOKEN>
<TOKEN end_char="2158" id="token-17-40" morph="none" pos="word" start_char="2149">reacciones</TOKEN>
<TOKEN end_char="2171" id="token-17-41" morph="none" pos="word" start_char="2160">relacionadas</TOKEN>
<TOKEN end_char="2175" id="token-17-42" morph="none" pos="word" start_char="2173">con</TOKEN>
<TOKEN end_char="2178" id="token-17-43" morph="none" pos="word" start_char="2177">la</TOKEN>
<TOKEN end_char="2188" id="token-17-44" morph="none" pos="word" start_char="2180">perfusión</TOKEN>
<TOKEN end_char="2189" id="token-17-45" morph="none" pos="punct" start_char="2189">:</TOKEN>
<TOKEN end_char="2195" id="token-17-46" morph="none" pos="word" start_char="2191">desde</TOKEN>
<TOKEN end_char="2203" id="token-17-47" morph="none" pos="word" start_char="2197">presión</TOKEN>
<TOKEN end_char="2212" id="token-17-48" morph="none" pos="word" start_char="2205">arterial</TOKEN>
<TOKEN end_char="2217" id="token-17-49" morph="none" pos="word" start_char="2214">baja</TOKEN>
<TOKEN end_char="2218" id="token-17-50" morph="none" pos="punct" start_char="2218">,</TOKEN>
<TOKEN end_char="2226" id="token-17-51" morph="none" pos="word" start_char="2220">pasando</TOKEN>
<TOKEN end_char="2230" id="token-17-52" morph="none" pos="word" start_char="2228">por</TOKEN>
<TOKEN end_char="2238" id="token-17-53" morph="none" pos="word" start_char="2232">náuseas</TOKEN>
<TOKEN end_char="2240" id="token-17-54" morph="none" pos="word" start_char="2240">y</TOKEN>
<TOKEN end_char="2248" id="token-17-55" morph="none" pos="word" start_char="2242">vómitos</TOKEN>
<TOKEN end_char="2249" id="token-17-56" morph="none" pos="punct" start_char="2249">,</TOKEN>
<TOKEN end_char="2255" id="token-17-57" morph="none" pos="word" start_char="2251">hasta</TOKEN>
<TOKEN end_char="2266" id="token-17-58" morph="none" pos="word" start_char="2257">sudoración</TOKEN>
<TOKEN end_char="2268" id="token-17-59" morph="none" pos="word" start_char="2268">y</TOKEN>
<TOKEN end_char="2280" id="token-17-60" morph="none" pos="word" start_char="2270">escalofríos</TOKEN>
<TOKEN end_char="2281" id="token-17-61" morph="none" pos="punct" start_char="2281">.</TOKEN>
<TRANSLATED_TEXT>Answer: The FDA has reported possible side effects of this drug, including increased liver enzyme levels - it can be a sign of inflammation or damage to liver cells - and perfusion-related reactions: from low blood pressure, through nausea and vomiting, to sweating and chills.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2345" id="segment-18" start_char="2284">
<ORIGINAL_TEXT>Pregunta: ¿En qué evidencias se han basado para su aprobación?</ORIGINAL_TEXT>
<TOKEN end_char="2291" id="token-18-0" morph="none" pos="word" start_char="2284">Pregunta</TOKEN>
<TOKEN end_char="2292" id="token-18-1" morph="none" pos="punct" start_char="2292">:</TOKEN>
<TOKEN end_char="2294" id="token-18-2" morph="none" pos="punct" start_char="2294">¿</TOKEN>
<TOKEN end_char="2296" id="token-18-3" morph="none" pos="word" start_char="2295">En</TOKEN>
<TOKEN end_char="2300" id="token-18-4" morph="none" pos="word" start_char="2298">qué</TOKEN>
<TOKEN end_char="2311" id="token-18-5" morph="none" pos="word" start_char="2302">evidencias</TOKEN>
<TOKEN end_char="2314" id="token-18-6" morph="none" pos="word" start_char="2313">se</TOKEN>
<TOKEN end_char="2318" id="token-18-7" morph="none" pos="word" start_char="2316">han</TOKEN>
<TOKEN end_char="2325" id="token-18-8" morph="none" pos="word" start_char="2320">basado</TOKEN>
<TOKEN end_char="2330" id="token-18-9" morph="none" pos="word" start_char="2327">para</TOKEN>
<TOKEN end_char="2333" id="token-18-10" morph="none" pos="word" start_char="2332">su</TOKEN>
<TOKEN end_char="2344" id="token-18-11" morph="none" pos="word" start_char="2335">aprobación</TOKEN>
<TOKEN end_char="2345" id="token-18-12" morph="none" pos="punct" start_char="2345">?</TOKEN>
<TRANSLATED_TEXT>Question: On what evidence have they based their approval?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2647" id="segment-19" start_char="2348">
<ORIGINAL_TEXT>Respuesta: La aprobación por la vía de la emergencia se produce por los resultados de un ensayo clínico federal realizado por el Instituto Nacional de Alergias y Enfermedades Infecciosas de EE.UU. (Niaid), que no ha sido revisado por científicos independientes ni publicado en una revista científica.</ORIGINAL_TEXT>
<TOKEN end_char="2356" id="token-19-0" morph="none" pos="word" start_char="2348">Respuesta</TOKEN>
<TOKEN end_char="2357" id="token-19-1" morph="none" pos="punct" start_char="2357">:</TOKEN>
<TOKEN end_char="2360" id="token-19-2" morph="none" pos="word" start_char="2359">La</TOKEN>
<TOKEN end_char="2371" id="token-19-3" morph="none" pos="word" start_char="2362">aprobación</TOKEN>
<TOKEN end_char="2375" id="token-19-4" morph="none" pos="word" start_char="2373">por</TOKEN>
<TOKEN end_char="2378" id="token-19-5" morph="none" pos="word" start_char="2377">la</TOKEN>
<TOKEN end_char="2382" id="token-19-6" morph="none" pos="word" start_char="2380">vía</TOKEN>
<TOKEN end_char="2385" id="token-19-7" morph="none" pos="word" start_char="2384">de</TOKEN>
<TOKEN end_char="2388" id="token-19-8" morph="none" pos="word" start_char="2387">la</TOKEN>
<TOKEN end_char="2399" id="token-19-9" morph="none" pos="word" start_char="2390">emergencia</TOKEN>
<TOKEN end_char="2402" id="token-19-10" morph="none" pos="word" start_char="2401">se</TOKEN>
<TOKEN end_char="2410" id="token-19-11" morph="none" pos="word" start_char="2404">produce</TOKEN>
<TOKEN end_char="2414" id="token-19-12" morph="none" pos="word" start_char="2412">por</TOKEN>
<TOKEN end_char="2418" id="token-19-13" morph="none" pos="word" start_char="2416">los</TOKEN>
<TOKEN end_char="2429" id="token-19-14" morph="none" pos="word" start_char="2420">resultados</TOKEN>
<TOKEN end_char="2432" id="token-19-15" morph="none" pos="word" start_char="2431">de</TOKEN>
<TOKEN end_char="2435" id="token-19-16" morph="none" pos="word" start_char="2434">un</TOKEN>
<TOKEN end_char="2442" id="token-19-17" morph="none" pos="word" start_char="2437">ensayo</TOKEN>
<TOKEN end_char="2450" id="token-19-18" morph="none" pos="word" start_char="2444">clínico</TOKEN>
<TOKEN end_char="2458" id="token-19-19" morph="none" pos="word" start_char="2452">federal</TOKEN>
<TOKEN end_char="2468" id="token-19-20" morph="none" pos="word" start_char="2460">realizado</TOKEN>
<TOKEN end_char="2472" id="token-19-21" morph="none" pos="word" start_char="2470">por</TOKEN>
<TOKEN end_char="2475" id="token-19-22" morph="none" pos="word" start_char="2474">el</TOKEN>
<TOKEN end_char="2485" id="token-19-23" morph="none" pos="word" start_char="2477">Instituto</TOKEN>
<TOKEN end_char="2494" id="token-19-24" morph="none" pos="word" start_char="2487">Nacional</TOKEN>
<TOKEN end_char="2497" id="token-19-25" morph="none" pos="word" start_char="2496">de</TOKEN>
<TOKEN end_char="2506" id="token-19-26" morph="none" pos="word" start_char="2499">Alergias</TOKEN>
<TOKEN end_char="2508" id="token-19-27" morph="none" pos="word" start_char="2508">y</TOKEN>
<TOKEN end_char="2521" id="token-19-28" morph="none" pos="word" start_char="2510">Enfermedades</TOKEN>
<TOKEN end_char="2533" id="token-19-29" morph="none" pos="word" start_char="2523">Infecciosas</TOKEN>
<TOKEN end_char="2536" id="token-19-30" morph="none" pos="word" start_char="2535">de</TOKEN>
<TOKEN end_char="2542" id="token-19-31" morph="none" pos="unknown" start_char="2538">EE.UU</TOKEN>
<TOKEN end_char="2543" id="token-19-32" morph="none" pos="punct" start_char="2543">.</TOKEN>
<TOKEN end_char="2545" id="token-19-33" morph="none" pos="punct" start_char="2545">(</TOKEN>
<TOKEN end_char="2550" id="token-19-34" morph="none" pos="word" start_char="2546">Niaid</TOKEN>
<TOKEN end_char="2552" id="token-19-35" morph="none" pos="punct" start_char="2551">),</TOKEN>
<TOKEN end_char="2556" id="token-19-36" morph="none" pos="word" start_char="2554">que</TOKEN>
<TOKEN end_char="2559" id="token-19-37" morph="none" pos="word" start_char="2558">no</TOKEN>
<TOKEN end_char="2562" id="token-19-38" morph="none" pos="word" start_char="2561">ha</TOKEN>
<TOKEN end_char="2567" id="token-19-39" morph="none" pos="word" start_char="2564">sido</TOKEN>
<TOKEN end_char="2576" id="token-19-40" morph="none" pos="word" start_char="2569">revisado</TOKEN>
<TOKEN end_char="2580" id="token-19-41" morph="none" pos="word" start_char="2578">por</TOKEN>
<TOKEN end_char="2592" id="token-19-42" morph="none" pos="word" start_char="2582">científicos</TOKEN>
<TOKEN end_char="2607" id="token-19-43" morph="none" pos="word" start_char="2594">independientes</TOKEN>
<TOKEN end_char="2610" id="token-19-44" morph="none" pos="word" start_char="2609">ni</TOKEN>
<TOKEN end_char="2620" id="token-19-45" morph="none" pos="word" start_char="2612">publicado</TOKEN>
<TOKEN end_char="2623" id="token-19-46" morph="none" pos="word" start_char="2622">en</TOKEN>
<TOKEN end_char="2627" id="token-19-47" morph="none" pos="word" start_char="2625">una</TOKEN>
<TOKEN end_char="2635" id="token-19-48" morph="none" pos="word" start_char="2629">revista</TOKEN>
<TOKEN end_char="2646" id="token-19-49" morph="none" pos="word" start_char="2637">científica</TOKEN>
<TOKEN end_char="2647" id="token-19-50" morph="none" pos="punct" start_char="2647">.</TOKEN>
<TRANSLATED_TEXT>Response: Emergency route approval results from a federal clinical trial conducted by the U.S. National Institute of Allergy and Infectious Diseases (Niaid), which has not been reviewed by independent scientists or published in a scientific journal.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2711" id="segment-20" start_char="2649">
<ORIGINAL_TEXT>Aunque los resultados son prometedores, aún faltan más ensayos.</ORIGINAL_TEXT>
<TOKEN end_char="2654" id="token-20-0" morph="none" pos="word" start_char="2649">Aunque</TOKEN>
<TOKEN end_char="2658" id="token-20-1" morph="none" pos="word" start_char="2656">los</TOKEN>
<TOKEN end_char="2669" id="token-20-2" morph="none" pos="word" start_char="2660">resultados</TOKEN>
<TOKEN end_char="2673" id="token-20-3" morph="none" pos="word" start_char="2671">son</TOKEN>
<TOKEN end_char="2686" id="token-20-4" morph="none" pos="word" start_char="2675">prometedores</TOKEN>
<TOKEN end_char="2687" id="token-20-5" morph="none" pos="punct" start_char="2687">,</TOKEN>
<TOKEN end_char="2691" id="token-20-6" morph="none" pos="word" start_char="2689">aún</TOKEN>
<TOKEN end_char="2698" id="token-20-7" morph="none" pos="word" start_char="2693">faltan</TOKEN>
<TOKEN end_char="2702" id="token-20-8" morph="none" pos="word" start_char="2700">más</TOKEN>
<TOKEN end_char="2710" id="token-20-9" morph="none" pos="word" start_char="2704">ensayos</TOKEN>
<TOKEN end_char="2711" id="token-20-10" morph="none" pos="punct" start_char="2711">.</TOKEN>
<TRANSLATED_TEXT>Although the results are promising, further testing is still lacking.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2847" id="segment-21" start_char="2713">
<ORIGINAL_TEXT>Gilead está desarrollando dos ensayos de fase 3, los estudios Simple, en países con alta prevalencia de Covid-19 (entre ellos, España).</ORIGINAL_TEXT>
<TOKEN end_char="2718" id="token-21-0" morph="none" pos="word" start_char="2713">Gilead</TOKEN>
<TOKEN end_char="2723" id="token-21-1" morph="none" pos="word" start_char="2720">está</TOKEN>
<TOKEN end_char="2737" id="token-21-2" morph="none" pos="word" start_char="2725">desarrollando</TOKEN>
<TOKEN end_char="2741" id="token-21-3" morph="none" pos="word" start_char="2739">dos</TOKEN>
<TOKEN end_char="2749" id="token-21-4" morph="none" pos="word" start_char="2743">ensayos</TOKEN>
<TOKEN end_char="2752" id="token-21-5" morph="none" pos="word" start_char="2751">de</TOKEN>
<TOKEN end_char="2757" id="token-21-6" morph="none" pos="word" start_char="2754">fase</TOKEN>
<TOKEN end_char="2759" id="token-21-7" morph="none" pos="word" start_char="2759">3</TOKEN>
<TOKEN end_char="2760" id="token-21-8" morph="none" pos="punct" start_char="2760">,</TOKEN>
<TOKEN end_char="2764" id="token-21-9" morph="none" pos="word" start_char="2762">los</TOKEN>
<TOKEN end_char="2773" id="token-21-10" morph="none" pos="word" start_char="2766">estudios</TOKEN>
<TOKEN end_char="2780" id="token-21-11" morph="none" pos="word" start_char="2775">Simple</TOKEN>
<TOKEN end_char="2781" id="token-21-12" morph="none" pos="punct" start_char="2781">,</TOKEN>
<TOKEN end_char="2784" id="token-21-13" morph="none" pos="word" start_char="2783">en</TOKEN>
<TOKEN end_char="2791" id="token-21-14" morph="none" pos="word" start_char="2786">países</TOKEN>
<TOKEN end_char="2795" id="token-21-15" morph="none" pos="word" start_char="2793">con</TOKEN>
<TOKEN end_char="2800" id="token-21-16" morph="none" pos="word" start_char="2797">alta</TOKEN>
<TOKEN end_char="2812" id="token-21-17" morph="none" pos="word" start_char="2802">prevalencia</TOKEN>
<TOKEN end_char="2815" id="token-21-18" morph="none" pos="word" start_char="2814">de</TOKEN>
<TOKEN end_char="2824" id="token-21-19" morph="none" pos="unknown" start_char="2817">Covid-19</TOKEN>
<TOKEN end_char="2826" id="token-21-20" morph="none" pos="punct" start_char="2826">(</TOKEN>
<TOKEN end_char="2831" id="token-21-21" morph="none" pos="word" start_char="2827">entre</TOKEN>
<TOKEN end_char="2837" id="token-21-22" morph="none" pos="word" start_char="2833">ellos</TOKEN>
<TOKEN end_char="2838" id="token-21-23" morph="none" pos="punct" start_char="2838">,</TOKEN>
<TOKEN end_char="2845" id="token-21-24" morph="none" pos="word" start_char="2840">España</TOKEN>
<TOKEN end_char="2847" id="token-21-25" morph="none" pos="punct" start_char="2846">).</TOKEN>
<TRANSLATED_TEXT>Gilead is developing two Phase 3 trials, the Simple Studies, in countries with high prevalence of Covid-19 (including Spain).</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2889" id="segment-22" start_char="2849">
<ORIGINAL_TEXT>Además, hace sólo cuatro días, la revista</ORIGINAL_TEXT>
<TOKEN end_char="2854" id="token-22-0" morph="none" pos="word" start_char="2849">Además</TOKEN>
<TOKEN end_char="2855" id="token-22-1" morph="none" pos="punct" start_char="2855">,</TOKEN>
<TOKEN end_char="2860" id="token-22-2" morph="none" pos="word" start_char="2857">hace</TOKEN>
<TOKEN end_char="2865" id="token-22-3" morph="none" pos="word" start_char="2862">sólo</TOKEN>
<TOKEN end_char="2872" id="token-22-4" morph="none" pos="word" start_char="2867">cuatro</TOKEN>
<TOKEN end_char="2877" id="token-22-5" morph="none" pos="word" start_char="2874">días</TOKEN>
<TOKEN end_char="2878" id="token-22-6" morph="none" pos="punct" start_char="2878">,</TOKEN>
<TOKEN end_char="2881" id="token-22-7" morph="none" pos="word" start_char="2880">la</TOKEN>
<TOKEN end_char="2889" id="token-22-8" morph="none" pos="word" start_char="2883">revista</TOKEN>
<TRANSLATED_TEXT>Besides, just four days ago, the magazine</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2901" id="segment-23" start_char="2892">
<ORIGINAL_TEXT>The Lancet</ORIGINAL_TEXT>
<TOKEN end_char="2894" id="token-23-0" morph="none" pos="word" start_char="2892">The</TOKEN>
<TOKEN end_char="2901" id="token-23-1" morph="none" pos="word" start_char="2896">Lancet</TOKEN>
</SEG>
<SEG end_char="3073" id="segment-24" start_char="2904">
<ORIGINAL_TEXT>publicaba los datos de un ensayo randomizado comparado con placebo llevado a cabo en hospitales de Wuhan (China), en el que se administraba el tratamiento a 237 enfermos.</ORIGINAL_TEXT>
<TOKEN end_char="2912" id="token-24-0" morph="none" pos="word" start_char="2904">publicaba</TOKEN>
<TOKEN end_char="2916" id="token-24-1" morph="none" pos="word" start_char="2914">los</TOKEN>
<TOKEN end_char="2922" id="token-24-2" morph="none" pos="word" start_char="2918">datos</TOKEN>
<TOKEN end_char="2925" id="token-24-3" morph="none" pos="word" start_char="2924">de</TOKEN>
<TOKEN end_char="2928" id="token-24-4" morph="none" pos="word" start_char="2927">un</TOKEN>
<TOKEN end_char="2935" id="token-24-5" morph="none" pos="word" start_char="2930">ensayo</TOKEN>
<TOKEN end_char="2947" id="token-24-6" morph="none" pos="word" start_char="2937">randomizado</TOKEN>
<TOKEN end_char="2957" id="token-24-7" morph="none" pos="word" start_char="2949">comparado</TOKEN>
<TOKEN end_char="2961" id="token-24-8" morph="none" pos="word" start_char="2959">con</TOKEN>
<TOKEN end_char="2969" id="token-24-9" morph="none" pos="word" start_char="2963">placebo</TOKEN>
<TOKEN end_char="2977" id="token-24-10" morph="none" pos="word" start_char="2971">llevado</TOKEN>
<TOKEN end_char="2979" id="token-24-11" morph="none" pos="word" start_char="2979">a</TOKEN>
<TOKEN end_char="2984" id="token-24-12" morph="none" pos="word" start_char="2981">cabo</TOKEN>
<TOKEN end_char="2987" id="token-24-13" morph="none" pos="word" start_char="2986">en</TOKEN>
<TOKEN end_char="2998" id="token-24-14" morph="none" pos="word" start_char="2989">hospitales</TOKEN>
<TOKEN end_char="3001" id="token-24-15" morph="none" pos="word" start_char="3000">de</TOKEN>
<TOKEN end_char="3007" id="token-24-16" morph="none" pos="word" start_char="3003">Wuhan</TOKEN>
<TOKEN end_char="3009" id="token-24-17" morph="none" pos="punct" start_char="3009">(</TOKEN>
<TOKEN end_char="3014" id="token-24-18" morph="none" pos="word" start_char="3010">China</TOKEN>
<TOKEN end_char="3016" id="token-24-19" morph="none" pos="punct" start_char="3015">),</TOKEN>
<TOKEN end_char="3019" id="token-24-20" morph="none" pos="word" start_char="3018">en</TOKEN>
<TOKEN end_char="3022" id="token-24-21" morph="none" pos="word" start_char="3021">el</TOKEN>
<TOKEN end_char="3026" id="token-24-22" morph="none" pos="word" start_char="3024">que</TOKEN>
<TOKEN end_char="3029" id="token-24-23" morph="none" pos="word" start_char="3028">se</TOKEN>
<TOKEN end_char="3042" id="token-24-24" morph="none" pos="word" start_char="3031">administraba</TOKEN>
<TOKEN end_char="3045" id="token-24-25" morph="none" pos="word" start_char="3044">el</TOKEN>
<TOKEN end_char="3057" id="token-24-26" morph="none" pos="word" start_char="3047">tratamiento</TOKEN>
<TOKEN end_char="3059" id="token-24-27" morph="none" pos="word" start_char="3059">a</TOKEN>
<TOKEN end_char="3063" id="token-24-28" morph="none" pos="word" start_char="3061">237</TOKEN>
<TOKEN end_char="3072" id="token-24-29" morph="none" pos="word" start_char="3065">enfermos</TOKEN>
<TOKEN end_char="3073" id="token-24-30" morph="none" pos="punct" start_char="3073">.</TOKEN>
<TRANSLATED_TEXT>published data from a randomized versus placebo trial conducted in hospitals in Wuhan, China, which treated 237 patients.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3228" id="segment-25" start_char="3075">
<ORIGINAL_TEXT>No se demostró la eficacia de remdesivir y aunque los datos indicaban que se acorta la duración de la enfermedad, no eran estadísticamente significativos.</ORIGINAL_TEXT>
<TOKEN end_char="3076" id="token-25-0" morph="none" pos="word" start_char="3075">No</TOKEN>
<TOKEN end_char="3079" id="token-25-1" morph="none" pos="word" start_char="3078">se</TOKEN>
<TOKEN end_char="3088" id="token-25-2" morph="none" pos="word" start_char="3081">demostró</TOKEN>
<TOKEN end_char="3091" id="token-25-3" morph="none" pos="word" start_char="3090">la</TOKEN>
<TOKEN end_char="3100" id="token-25-4" morph="none" pos="word" start_char="3093">eficacia</TOKEN>
<TOKEN end_char="3103" id="token-25-5" morph="none" pos="word" start_char="3102">de</TOKEN>
<TOKEN end_char="3114" id="token-25-6" morph="none" pos="word" start_char="3105">remdesivir</TOKEN>
<TOKEN end_char="3116" id="token-25-7" morph="none" pos="word" start_char="3116">y</TOKEN>
<TOKEN end_char="3123" id="token-25-8" morph="none" pos="word" start_char="3118">aunque</TOKEN>
<TOKEN end_char="3127" id="token-25-9" morph="none" pos="word" start_char="3125">los</TOKEN>
<TOKEN end_char="3133" id="token-25-10" morph="none" pos="word" start_char="3129">datos</TOKEN>
<TOKEN end_char="3143" id="token-25-11" morph="none" pos="word" start_char="3135">indicaban</TOKEN>
<TOKEN end_char="3147" id="token-25-12" morph="none" pos="word" start_char="3145">que</TOKEN>
<TOKEN end_char="3150" id="token-25-13" morph="none" pos="word" start_char="3149">se</TOKEN>
<TOKEN end_char="3157" id="token-25-14" morph="none" pos="word" start_char="3152">acorta</TOKEN>
<TOKEN end_char="3160" id="token-25-15" morph="none" pos="word" start_char="3159">la</TOKEN>
<TOKEN end_char="3169" id="token-25-16" morph="none" pos="word" start_char="3162">duración</TOKEN>
<TOKEN end_char="3172" id="token-25-17" morph="none" pos="word" start_char="3171">de</TOKEN>
<TOKEN end_char="3175" id="token-25-18" morph="none" pos="word" start_char="3174">la</TOKEN>
<TOKEN end_char="3186" id="token-25-19" morph="none" pos="word" start_char="3177">enfermedad</TOKEN>
<TOKEN end_char="3187" id="token-25-20" morph="none" pos="punct" start_char="3187">,</TOKEN>
<TOKEN end_char="3190" id="token-25-21" morph="none" pos="word" start_char="3189">no</TOKEN>
<TOKEN end_char="3195" id="token-25-22" morph="none" pos="word" start_char="3192">eran</TOKEN>
<TOKEN end_char="3212" id="token-25-23" morph="none" pos="word" start_char="3197">estadísticamente</TOKEN>
<TOKEN end_char="3227" id="token-25-24" morph="none" pos="word" start_char="3214">significativos</TOKEN>
<TOKEN end_char="3228" id="token-25-25" morph="none" pos="punct" start_char="3228">.</TOKEN>
<TRANSLATED_TEXT>The efficacy of remdesivir was not demonstrated and although the data indicated that the duration of the disease was shortened, they were not statistically significant.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3376" id="segment-26" start_char="3231">
<ORIGINAL_TEXT>La farmacéutica Gilead anunció el miércoles que el tratamiento con remdesivir mejora el estado clínico de pacientes con formas graves de Covid-19.</ORIGINAL_TEXT>
<TOKEN end_char="3232" id="token-26-0" morph="none" pos="word" start_char="3231">La</TOKEN>
<TOKEN end_char="3245" id="token-26-1" morph="none" pos="word" start_char="3234">farmacéutica</TOKEN>
<TOKEN end_char="3252" id="token-26-2" morph="none" pos="word" start_char="3247">Gilead</TOKEN>
<TOKEN end_char="3260" id="token-26-3" morph="none" pos="word" start_char="3254">anunció</TOKEN>
<TOKEN end_char="3263" id="token-26-4" morph="none" pos="word" start_char="3262">el</TOKEN>
<TOKEN end_char="3273" id="token-26-5" morph="none" pos="word" start_char="3265">miércoles</TOKEN>
<TOKEN end_char="3277" id="token-26-6" morph="none" pos="word" start_char="3275">que</TOKEN>
<TOKEN end_char="3280" id="token-26-7" morph="none" pos="word" start_char="3279">el</TOKEN>
<TOKEN end_char="3292" id="token-26-8" morph="none" pos="word" start_char="3282">tratamiento</TOKEN>
<TOKEN end_char="3296" id="token-26-9" morph="none" pos="word" start_char="3294">con</TOKEN>
<TOKEN end_char="3307" id="token-26-10" morph="none" pos="word" start_char="3298">remdesivir</TOKEN>
<TOKEN end_char="3314" id="token-26-11" morph="none" pos="word" start_char="3309">mejora</TOKEN>
<TOKEN end_char="3317" id="token-26-12" morph="none" pos="word" start_char="3316">el</TOKEN>
<TOKEN end_char="3324" id="token-26-13" morph="none" pos="word" start_char="3319">estado</TOKEN>
<TOKEN end_char="3332" id="token-26-14" morph="none" pos="word" start_char="3326">clínico</TOKEN>
<TOKEN end_char="3335" id="token-26-15" morph="none" pos="word" start_char="3334">de</TOKEN>
<TOKEN end_char="3345" id="token-26-16" morph="none" pos="word" start_char="3337">pacientes</TOKEN>
<TOKEN end_char="3349" id="token-26-17" morph="none" pos="word" start_char="3347">con</TOKEN>
<TOKEN end_char="3356" id="token-26-18" morph="none" pos="word" start_char="3351">formas</TOKEN>
<TOKEN end_char="3363" id="token-26-19" morph="none" pos="word" start_char="3358">graves</TOKEN>
<TOKEN end_char="3366" id="token-26-20" morph="none" pos="word" start_char="3365">de</TOKEN>
<TOKEN end_char="3375" id="token-26-21" morph="none" pos="unknown" start_char="3368">Covid-19</TOKEN>
<TOKEN end_char="3376" id="token-26-22" morph="none" pos="punct" start_char="3376">.</TOKEN>
<TRANSLATED_TEXT>Gilead Pharmaceuticals announced on Wednesday that remdesivir treatment improves the clinical status of patients with severe forms of Covid-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3529" id="segment-27" start_char="3378">
<ORIGINAL_TEXT>Se daba en casi un 65% de los tratados que además no sufrían grandes efectos secundarios y obtienen un beneficio a los cinco días de recibir el fármaco.</ORIGINAL_TEXT>
<TOKEN end_char="3379" id="token-27-0" morph="none" pos="word" start_char="3378">Se</TOKEN>
<TOKEN end_char="3384" id="token-27-1" morph="none" pos="word" start_char="3381">daba</TOKEN>
<TOKEN end_char="3387" id="token-27-2" morph="none" pos="word" start_char="3386">en</TOKEN>
<TOKEN end_char="3392" id="token-27-3" morph="none" pos="word" start_char="3389">casi</TOKEN>
<TOKEN end_char="3395" id="token-27-4" morph="none" pos="word" start_char="3394">un</TOKEN>
<TOKEN end_char="3398" id="token-27-5" morph="none" pos="word" start_char="3397">65</TOKEN>
<TOKEN end_char="3399" id="token-27-6" morph="none" pos="punct" start_char="3399">%</TOKEN>
<TOKEN end_char="3402" id="token-27-7" morph="none" pos="word" start_char="3401">de</TOKEN>
<TOKEN end_char="3406" id="token-27-8" morph="none" pos="word" start_char="3404">los</TOKEN>
<TOKEN end_char="3415" id="token-27-9" morph="none" pos="word" start_char="3408">tratados</TOKEN>
<TOKEN end_char="3419" id="token-27-10" morph="none" pos="word" start_char="3417">que</TOKEN>
<TOKEN end_char="3426" id="token-27-11" morph="none" pos="word" start_char="3421">además</TOKEN>
<TOKEN end_char="3429" id="token-27-12" morph="none" pos="word" start_char="3428">no</TOKEN>
<TOKEN end_char="3437" id="token-27-13" morph="none" pos="word" start_char="3431">sufrían</TOKEN>
<TOKEN end_char="3445" id="token-27-14" morph="none" pos="word" start_char="3439">grandes</TOKEN>
<TOKEN end_char="3453" id="token-27-15" morph="none" pos="word" start_char="3447">efectos</TOKEN>
<TOKEN end_char="3465" id="token-27-16" morph="none" pos="word" start_char="3455">secundarios</TOKEN>
<TOKEN end_char="3467" id="token-27-17" morph="none" pos="word" start_char="3467">y</TOKEN>
<TOKEN end_char="3476" id="token-27-18" morph="none" pos="word" start_char="3469">obtienen</TOKEN>
<TOKEN end_char="3479" id="token-27-19" morph="none" pos="word" start_char="3478">un</TOKEN>
<TOKEN end_char="3489" id="token-27-20" morph="none" pos="word" start_char="3481">beneficio</TOKEN>
<TOKEN end_char="3491" id="token-27-21" morph="none" pos="word" start_char="3491">a</TOKEN>
<TOKEN end_char="3495" id="token-27-22" morph="none" pos="word" start_char="3493">los</TOKEN>
<TOKEN end_char="3501" id="token-27-23" morph="none" pos="word" start_char="3497">cinco</TOKEN>
<TOKEN end_char="3506" id="token-27-24" morph="none" pos="word" start_char="3503">días</TOKEN>
<TOKEN end_char="3509" id="token-27-25" morph="none" pos="word" start_char="3508">de</TOKEN>
<TOKEN end_char="3517" id="token-27-26" morph="none" pos="word" start_char="3511">recibir</TOKEN>
<TOKEN end_char="3520" id="token-27-27" morph="none" pos="word" start_char="3519">el</TOKEN>
<TOKEN end_char="3528" id="token-27-28" morph="none" pos="word" start_char="3522">fármaco</TOKEN>
<TOKEN end_char="3529" id="token-27-29" morph="none" pos="punct" start_char="3529">.</TOKEN>
<TRANSLATED_TEXT>It was given in almost 65% of the treatments that also did not have major side effects and gained a benefit within five days of receiving the drug.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3605" id="segment-28" start_char="3531">
<ORIGINAL_TEXT>En esa línea está un pequeño estudio preliminar publicado el 10 de abril en</ORIGINAL_TEXT>
<TOKEN end_char="3532" id="token-28-0" morph="none" pos="word" start_char="3531">En</TOKEN>
<TOKEN end_char="3536" id="token-28-1" morph="none" pos="word" start_char="3534">esa</TOKEN>
<TOKEN end_char="3542" id="token-28-2" morph="none" pos="word" start_char="3538">línea</TOKEN>
<TOKEN end_char="3547" id="token-28-3" morph="none" pos="word" start_char="3544">está</TOKEN>
<TOKEN end_char="3550" id="token-28-4" morph="none" pos="word" start_char="3549">un</TOKEN>
<TOKEN end_char="3558" id="token-28-5" morph="none" pos="word" start_char="3552">pequeño</TOKEN>
<TOKEN end_char="3566" id="token-28-6" morph="none" pos="word" start_char="3560">estudio</TOKEN>
<TOKEN end_char="3577" id="token-28-7" morph="none" pos="word" start_char="3568">preliminar</TOKEN>
<TOKEN end_char="3587" id="token-28-8" morph="none" pos="word" start_char="3579">publicado</TOKEN>
<TOKEN end_char="3590" id="token-28-9" morph="none" pos="word" start_char="3589">el</TOKEN>
<TOKEN end_char="3593" id="token-28-10" morph="none" pos="word" start_char="3592">10</TOKEN>
<TOKEN end_char="3596" id="token-28-11" morph="none" pos="word" start_char="3595">de</TOKEN>
<TOKEN end_char="3602" id="token-28-12" morph="none" pos="word" start_char="3598">abril</TOKEN>
<TOKEN end_char="3605" id="token-28-13" morph="none" pos="word" start_char="3604">en</TOKEN>
<TRANSLATED_TEXT>On that line is a small preliminary study published on April 10 in</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3642" id="segment-29" start_char="3608">
<ORIGINAL_TEXT>The New England Journal of Medicine</ORIGINAL_TEXT>
<TOKEN end_char="3610" id="token-29-0" morph="none" pos="word" start_char="3608">The</TOKEN>
<TOKEN end_char="3614" id="token-29-1" morph="none" pos="word" start_char="3612">New</TOKEN>
<TOKEN end_char="3622" id="token-29-2" morph="none" pos="word" start_char="3616">England</TOKEN>
<TOKEN end_char="3630" id="token-29-3" morph="none" pos="word" start_char="3624">Journal</TOKEN>
<TOKEN end_char="3633" id="token-29-4" morph="none" pos="word" start_char="3632">of</TOKEN>
<TOKEN end_char="3642" id="token-29-5" morph="none" pos="word" start_char="3635">Medicine</TOKEN>
</SEG>
<SEG end_char="3827" id="segment-30" start_char="3645">
<ORIGINAL_TEXT>, en el que participa el Hospital La Paz de Madrid, que concluye que cerca de los dos tercios de pacientes muy graves mejoraban al recibir el tratamiento por la vía del uso compasivo.</ORIGINAL_TEXT>
<TOKEN end_char="3645" id="token-30-0" morph="none" pos="punct" start_char="3645">,</TOKEN>
<TOKEN end_char="3648" id="token-30-1" morph="none" pos="word" start_char="3647">en</TOKEN>
<TOKEN end_char="3651" id="token-30-2" morph="none" pos="word" start_char="3650">el</TOKEN>
<TOKEN end_char="3655" id="token-30-3" morph="none" pos="word" start_char="3653">que</TOKEN>
<TOKEN end_char="3665" id="token-30-4" morph="none" pos="word" start_char="3657">participa</TOKEN>
<TOKEN end_char="3668" id="token-30-5" morph="none" pos="word" start_char="3667">el</TOKEN>
<TOKEN end_char="3677" id="token-30-6" morph="none" pos="word" start_char="3670">Hospital</TOKEN>
<TOKEN end_char="3680" id="token-30-7" morph="none" pos="word" start_char="3679">La</TOKEN>
<TOKEN end_char="3684" id="token-30-8" morph="none" pos="word" start_char="3682">Paz</TOKEN>
<TOKEN end_char="3687" id="token-30-9" morph="none" pos="word" start_char="3686">de</TOKEN>
<TOKEN end_char="3694" id="token-30-10" morph="none" pos="word" start_char="3689">Madrid</TOKEN>
<TOKEN end_char="3695" id="token-30-11" morph="none" pos="punct" start_char="3695">,</TOKEN>
<TOKEN end_char="3699" id="token-30-12" morph="none" pos="word" start_char="3697">que</TOKEN>
<TOKEN end_char="3708" id="token-30-13" morph="none" pos="word" start_char="3701">concluye</TOKEN>
<TOKEN end_char="3712" id="token-30-14" morph="none" pos="word" start_char="3710">que</TOKEN>
<TOKEN end_char="3718" id="token-30-15" morph="none" pos="word" start_char="3714">cerca</TOKEN>
<TOKEN end_char="3721" id="token-30-16" morph="none" pos="word" start_char="3720">de</TOKEN>
<TOKEN end_char="3725" id="token-30-17" morph="none" pos="word" start_char="3723">los</TOKEN>
<TOKEN end_char="3729" id="token-30-18" morph="none" pos="word" start_char="3727">dos</TOKEN>
<TOKEN end_char="3737" id="token-30-19" morph="none" pos="word" start_char="3731">tercios</TOKEN>
<TOKEN end_char="3740" id="token-30-20" morph="none" pos="word" start_char="3739">de</TOKEN>
<TOKEN end_char="3750" id="token-30-21" morph="none" pos="word" start_char="3742">pacientes</TOKEN>
<TOKEN end_char="3754" id="token-30-22" morph="none" pos="word" start_char="3752">muy</TOKEN>
<TOKEN end_char="3761" id="token-30-23" morph="none" pos="word" start_char="3756">graves</TOKEN>
<TOKEN end_char="3771" id="token-30-24" morph="none" pos="word" start_char="3763">mejoraban</TOKEN>
<TOKEN end_char="3774" id="token-30-25" morph="none" pos="word" start_char="3773">al</TOKEN>
<TOKEN end_char="3782" id="token-30-26" morph="none" pos="word" start_char="3776">recibir</TOKEN>
<TOKEN end_char="3785" id="token-30-27" morph="none" pos="word" start_char="3784">el</TOKEN>
<TOKEN end_char="3797" id="token-30-28" morph="none" pos="word" start_char="3787">tratamiento</TOKEN>
<TOKEN end_char="3801" id="token-30-29" morph="none" pos="word" start_char="3799">por</TOKEN>
<TOKEN end_char="3804" id="token-30-30" morph="none" pos="word" start_char="3803">la</TOKEN>
<TOKEN end_char="3808" id="token-30-31" morph="none" pos="word" start_char="3806">vía</TOKEN>
<TOKEN end_char="3812" id="token-30-32" morph="none" pos="word" start_char="3810">del</TOKEN>
<TOKEN end_char="3816" id="token-30-33" morph="none" pos="word" start_char="3814">uso</TOKEN>
<TOKEN end_char="3826" id="token-30-34" morph="none" pos="word" start_char="3818">compasivo</TOKEN>
<TOKEN end_char="3827" id="token-30-35" morph="none" pos="punct" start_char="3827">.</TOKEN>
<TRANSLATED_TEXT>, in which the Hospital La Paz in Madrid participates, which concludes that about two-thirds of very serious patients improved upon receiving treatment through compassionate use.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3938" id="segment-31" start_char="3829">
<ORIGINAL_TEXT>Aun con todo, en Gilead se muestran cautos e insisten en que aún se está investigando la eficacia del fármaco.</ORIGINAL_TEXT>
<TOKEN end_char="3831" id="token-31-0" morph="none" pos="word" start_char="3829">Aun</TOKEN>
<TOKEN end_char="3835" id="token-31-1" morph="none" pos="word" start_char="3833">con</TOKEN>
<TOKEN end_char="3840" id="token-31-2" morph="none" pos="word" start_char="3837">todo</TOKEN>
<TOKEN end_char="3841" id="token-31-3" morph="none" pos="punct" start_char="3841">,</TOKEN>
<TOKEN end_char="3844" id="token-31-4" morph="none" pos="word" start_char="3843">en</TOKEN>
<TOKEN end_char="3851" id="token-31-5" morph="none" pos="word" start_char="3846">Gilead</TOKEN>
<TOKEN end_char="3854" id="token-31-6" morph="none" pos="word" start_char="3853">se</TOKEN>
<TOKEN end_char="3863" id="token-31-7" morph="none" pos="word" start_char="3856">muestran</TOKEN>
<TOKEN end_char="3870" id="token-31-8" morph="none" pos="word" start_char="3865">cautos</TOKEN>
<TOKEN end_char="3872" id="token-31-9" morph="none" pos="word" start_char="3872">e</TOKEN>
<TOKEN end_char="3881" id="token-31-10" morph="none" pos="word" start_char="3874">insisten</TOKEN>
<TOKEN end_char="3884" id="token-31-11" morph="none" pos="word" start_char="3883">en</TOKEN>
<TOKEN end_char="3888" id="token-31-12" morph="none" pos="word" start_char="3886">que</TOKEN>
<TOKEN end_char="3892" id="token-31-13" morph="none" pos="word" start_char="3890">aún</TOKEN>
<TOKEN end_char="3895" id="token-31-14" morph="none" pos="word" start_char="3894">se</TOKEN>
<TOKEN end_char="3900" id="token-31-15" morph="none" pos="word" start_char="3897">está</TOKEN>
<TOKEN end_char="3913" id="token-31-16" morph="none" pos="word" start_char="3902">investigando</TOKEN>
<TOKEN end_char="3916" id="token-31-17" morph="none" pos="word" start_char="3915">la</TOKEN>
<TOKEN end_char="3925" id="token-31-18" morph="none" pos="word" start_char="3918">eficacia</TOKEN>
<TOKEN end_char="3929" id="token-31-19" morph="none" pos="word" start_char="3927">del</TOKEN>
<TOKEN end_char="3937" id="token-31-20" morph="none" pos="word" start_char="3931">fármaco</TOKEN>
<TOKEN end_char="3938" id="token-31-21" morph="none" pos="punct" start_char="3938">.</TOKEN>
<TRANSLATED_TEXT>Still, Gilead is cautious and insists that the efficacy of the drug is still being investigated.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3981" id="segment-32" start_char="3941">
<ORIGINAL_TEXT>Pregunta: ¿Cuándo podría llegar a España?</ORIGINAL_TEXT>
<TOKEN end_char="3948" id="token-32-0" morph="none" pos="word" start_char="3941">Pregunta</TOKEN>
<TOKEN end_char="3949" id="token-32-1" morph="none" pos="punct" start_char="3949">:</TOKEN>
<TOKEN end_char="3951" id="token-32-2" morph="none" pos="punct" start_char="3951">¿</TOKEN>
<TOKEN end_char="3957" id="token-32-3" morph="none" pos="word" start_char="3952">Cuándo</TOKEN>
<TOKEN end_char="3964" id="token-32-4" morph="none" pos="word" start_char="3959">podría</TOKEN>
<TOKEN end_char="3971" id="token-32-5" morph="none" pos="word" start_char="3966">llegar</TOKEN>
<TOKEN end_char="3973" id="token-32-6" morph="none" pos="word" start_char="3973">a</TOKEN>
<TOKEN end_char="3980" id="token-32-7" morph="none" pos="word" start_char="3975">España</TOKEN>
<TOKEN end_char="3981" id="token-32-8" morph="none" pos="punct" start_char="3981">?</TOKEN>
<TRANSLATED_TEXT>Question: When could I reach Spain?</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4099" id="segment-33" start_char="3984">
<ORIGINAL_TEXT>Respuesta: De momento es una autorización de emergencia (no está aprobado definitivamente) sólo para Estados Unidos.</ORIGINAL_TEXT>
<TOKEN end_char="3992" id="token-33-0" morph="none" pos="word" start_char="3984">Respuesta</TOKEN>
<TOKEN end_char="3993" id="token-33-1" morph="none" pos="punct" start_char="3993">:</TOKEN>
<TOKEN end_char="3996" id="token-33-2" morph="none" pos="word" start_char="3995">De</TOKEN>
<TOKEN end_char="4004" id="token-33-3" morph="none" pos="word" start_char="3998">momento</TOKEN>
<TOKEN end_char="4007" id="token-33-4" morph="none" pos="word" start_char="4006">es</TOKEN>
<TOKEN end_char="4011" id="token-33-5" morph="none" pos="word" start_char="4009">una</TOKEN>
<TOKEN end_char="4024" id="token-33-6" morph="none" pos="word" start_char="4013">autorización</TOKEN>
<TOKEN end_char="4027" id="token-33-7" morph="none" pos="word" start_char="4026">de</TOKEN>
<TOKEN end_char="4038" id="token-33-8" morph="none" pos="word" start_char="4029">emergencia</TOKEN>
<TOKEN end_char="4040" id="token-33-9" morph="none" pos="punct" start_char="4040">(</TOKEN>
<TOKEN end_char="4042" id="token-33-10" morph="none" pos="word" start_char="4041">no</TOKEN>
<TOKEN end_char="4047" id="token-33-11" morph="none" pos="word" start_char="4044">está</TOKEN>
<TOKEN end_char="4056" id="token-33-12" morph="none" pos="word" start_char="4049">aprobado</TOKEN>
<TOKEN end_char="4072" id="token-33-13" morph="none" pos="word" start_char="4058">definitivamente</TOKEN>
<TOKEN end_char="4073" id="token-33-14" morph="none" pos="punct" start_char="4073">)</TOKEN>
<TOKEN end_char="4078" id="token-33-15" morph="none" pos="word" start_char="4075">sólo</TOKEN>
<TOKEN end_char="4083" id="token-33-16" morph="none" pos="word" start_char="4080">para</TOKEN>
<TOKEN end_char="4091" id="token-33-17" morph="none" pos="word" start_char="4085">Estados</TOKEN>
<TOKEN end_char="4098" id="token-33-18" morph="none" pos="word" start_char="4093">Unidos</TOKEN>
<TOKEN end_char="4099" id="token-33-19" morph="none" pos="punct" start_char="4099">.</TOKEN>
<TRANSLATED_TEXT>Answer: It is currently an emergency authorization (not definitively approved) for the United States only.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4329" id="segment-34" start_char="4101">
<ORIGINAL_TEXT>Para que llegue a Europa debe ser aprobado por la Agencia Europea del Medicamento (EMA) y, concretamente en España, depende de la Agencia Española de Medicamentos y Productos Sanitarios (Aemps), entidad del Ministerio de Sanidad.</ORIGINAL_TEXT>
<TOKEN end_char="4104" id="token-34-0" morph="none" pos="word" start_char="4101">Para</TOKEN>
<TOKEN end_char="4108" id="token-34-1" morph="none" pos="word" start_char="4106">que</TOKEN>
<TOKEN end_char="4115" id="token-34-2" morph="none" pos="word" start_char="4110">llegue</TOKEN>
<TOKEN end_char="4117" id="token-34-3" morph="none" pos="word" start_char="4117">a</TOKEN>
<TOKEN end_char="4124" id="token-34-4" morph="none" pos="word" start_char="4119">Europa</TOKEN>
<TOKEN end_char="4129" id="token-34-5" morph="none" pos="word" start_char="4126">debe</TOKEN>
<TOKEN end_char="4133" id="token-34-6" morph="none" pos="word" start_char="4131">ser</TOKEN>
<TOKEN end_char="4142" id="token-34-7" morph="none" pos="word" start_char="4135">aprobado</TOKEN>
<TOKEN end_char="4146" id="token-34-8" morph="none" pos="word" start_char="4144">por</TOKEN>
<TOKEN end_char="4149" id="token-34-9" morph="none" pos="word" start_char="4148">la</TOKEN>
<TOKEN end_char="4157" id="token-34-10" morph="none" pos="word" start_char="4151">Agencia</TOKEN>
<TOKEN end_char="4165" id="token-34-11" morph="none" pos="word" start_char="4159">Europea</TOKEN>
<TOKEN end_char="4169" id="token-34-12" morph="none" pos="word" start_char="4167">del</TOKEN>
<TOKEN end_char="4181" id="token-34-13" morph="none" pos="word" start_char="4171">Medicamento</TOKEN>
<TOKEN end_char="4183" id="token-34-14" morph="none" pos="punct" start_char="4183">(</TOKEN>
<TOKEN end_char="4186" id="token-34-15" morph="none" pos="word" start_char="4184">EMA</TOKEN>
<TOKEN end_char="4187" id="token-34-16" morph="none" pos="punct" start_char="4187">)</TOKEN>
<TOKEN end_char="4189" id="token-34-17" morph="none" pos="word" start_char="4189">y</TOKEN>
<TOKEN end_char="4190" id="token-34-18" morph="none" pos="punct" start_char="4190">,</TOKEN>
<TOKEN end_char="4204" id="token-34-19" morph="none" pos="word" start_char="4192">concretamente</TOKEN>
<TOKEN end_char="4207" id="token-34-20" morph="none" pos="word" start_char="4206">en</TOKEN>
<TOKEN end_char="4214" id="token-34-21" morph="none" pos="word" start_char="4209">España</TOKEN>
<TOKEN end_char="4215" id="token-34-22" morph="none" pos="punct" start_char="4215">,</TOKEN>
<TOKEN end_char="4223" id="token-34-23" morph="none" pos="word" start_char="4217">depende</TOKEN>
<TOKEN end_char="4226" id="token-34-24" morph="none" pos="word" start_char="4225">de</TOKEN>
<TOKEN end_char="4229" id="token-34-25" morph="none" pos="word" start_char="4228">la</TOKEN>
<TOKEN end_char="4237" id="token-34-26" morph="none" pos="word" start_char="4231">Agencia</TOKEN>
<TOKEN end_char="4246" id="token-34-27" morph="none" pos="word" start_char="4239">Española</TOKEN>
<TOKEN end_char="4249" id="token-34-28" morph="none" pos="word" start_char="4248">de</TOKEN>
<TOKEN end_char="4262" id="token-34-29" morph="none" pos="word" start_char="4251">Medicamentos</TOKEN>
<TOKEN end_char="4264" id="token-34-30" morph="none" pos="word" start_char="4264">y</TOKEN>
<TOKEN end_char="4274" id="token-34-31" morph="none" pos="word" start_char="4266">Productos</TOKEN>
<TOKEN end_char="4285" id="token-34-32" morph="none" pos="word" start_char="4276">Sanitarios</TOKEN>
<TOKEN end_char="4287" id="token-34-33" morph="none" pos="punct" start_char="4287">(</TOKEN>
<TOKEN end_char="4292" id="token-34-34" morph="none" pos="word" start_char="4288">Aemps</TOKEN>
<TOKEN end_char="4294" id="token-34-35" morph="none" pos="punct" start_char="4293">),</TOKEN>
<TOKEN end_char="4302" id="token-34-36" morph="none" pos="word" start_char="4296">entidad</TOKEN>
<TOKEN end_char="4306" id="token-34-37" morph="none" pos="word" start_char="4304">del</TOKEN>
<TOKEN end_char="4317" id="token-34-38" morph="none" pos="word" start_char="4308">Ministerio</TOKEN>
<TOKEN end_char="4320" id="token-34-39" morph="none" pos="word" start_char="4319">de</TOKEN>
<TOKEN end_char="4328" id="token-34-40" morph="none" pos="word" start_char="4322">Sanidad</TOKEN>
<TOKEN end_char="4329" id="token-34-41" morph="none" pos="punct" start_char="4329">.</TOKEN>
<TRANSLATED_TEXT>In order to arrive in Europe it must be approved by the European Medicines Agency (EMA) and, specifically in Spain, it depends on the Spanish Agency for Medicinal Products and Health Products (AMPs), entity of the Ministry of Health.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4475" id="segment-35" start_char="4331">
<ORIGINAL_TEXT>Esta semana, en cambio, estará ya disponible en EEUU para los pacientes más graves de Covid-19, según anunció la farmacéutica este mismo domingo.</ORIGINAL_TEXT>
<TOKEN end_char="4334" id="token-35-0" morph="none" pos="word" start_char="4331">Esta</TOKEN>
<TOKEN end_char="4341" id="token-35-1" morph="none" pos="word" start_char="4336">semana</TOKEN>
<TOKEN end_char="4342" id="token-35-2" morph="none" pos="punct" start_char="4342">,</TOKEN>
<TOKEN end_char="4345" id="token-35-3" morph="none" pos="word" start_char="4344">en</TOKEN>
<TOKEN end_char="4352" id="token-35-4" morph="none" pos="word" start_char="4347">cambio</TOKEN>
<TOKEN end_char="4353" id="token-35-5" morph="none" pos="punct" start_char="4353">,</TOKEN>
<TOKEN end_char="4360" id="token-35-6" morph="none" pos="word" start_char="4355">estará</TOKEN>
<TOKEN end_char="4363" id="token-35-7" morph="none" pos="word" start_char="4362">ya</TOKEN>
<TOKEN end_char="4374" id="token-35-8" morph="none" pos="word" start_char="4365">disponible</TOKEN>
<TOKEN end_char="4377" id="token-35-9" morph="none" pos="word" start_char="4376">en</TOKEN>
<TOKEN end_char="4382" id="token-35-10" morph="none" pos="word" start_char="4379">EEUU</TOKEN>
<TOKEN end_char="4387" id="token-35-11" morph="none" pos="word" start_char="4384">para</TOKEN>
<TOKEN end_char="4391" id="token-35-12" morph="none" pos="word" start_char="4389">los</TOKEN>
<TOKEN end_char="4401" id="token-35-13" morph="none" pos="word" start_char="4393">pacientes</TOKEN>
<TOKEN end_char="4405" id="token-35-14" morph="none" pos="word" start_char="4403">más</TOKEN>
<TOKEN end_char="4412" id="token-35-15" morph="none" pos="word" start_char="4407">graves</TOKEN>
<TOKEN end_char="4415" id="token-35-16" morph="none" pos="word" start_char="4414">de</TOKEN>
<TOKEN end_char="4424" id="token-35-17" morph="none" pos="unknown" start_char="4417">Covid-19</TOKEN>
<TOKEN end_char="4425" id="token-35-18" morph="none" pos="punct" start_char="4425">,</TOKEN>
<TOKEN end_char="4431" id="token-35-19" morph="none" pos="word" start_char="4427">según</TOKEN>
<TOKEN end_char="4439" id="token-35-20" morph="none" pos="word" start_char="4433">anunció</TOKEN>
<TOKEN end_char="4442" id="token-35-21" morph="none" pos="word" start_char="4441">la</TOKEN>
<TOKEN end_char="4455" id="token-35-22" morph="none" pos="word" start_char="4444">farmacéutica</TOKEN>
<TOKEN end_char="4460" id="token-35-23" morph="none" pos="word" start_char="4457">este</TOKEN>
<TOKEN end_char="4466" id="token-35-24" morph="none" pos="word" start_char="4462">mismo</TOKEN>
<TOKEN end_char="4474" id="token-35-25" morph="none" pos="word" start_char="4468">domingo</TOKEN>
<TOKEN end_char="4475" id="token-35-26" morph="none" pos="punct" start_char="4475">.</TOKEN>
<TRANSLATED_TEXT>This week, by contrast, it will already be available in the US for the most serious patients of Covid-19, as announced by the pharmaceutical this Sunday.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>